<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">KZWg3LwfjymfC5nyvz7JWqN</article-id>
      <article-id pub-id-type="other">00013</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2011001500013</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(11)09700613</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2011001500013</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo de Revis&#227;o</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Avalia&#231;&#227;o da qualidade de vida ap&#243;s s&#237;ndrome coronariana aguda: revis&#227;o sistem&#225;tica</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>Suzana Alves da</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Passos</surname>
            <given-names>Sonia Regina Lambert</given-names>
          </name>
          <xref ref-type="aff" rid="aff04"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carballo</surname>
            <given-names>Mariana Teixeira</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Figueir&#243;</surname>
            <given-names>Mabel</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
      </contrib-group>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Centro de Ensino e Pesquisa do Pr&#243;-Card&#237;aco</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff04">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">RJ</named-content>
        </addr-line>
        <institution content-type="orgname">Instituto de Pesquisa Cl&#237;nica Evandro Chagas</institution>
        <country country="BR">Brasil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">Hospital do Cora&#231;&#227;o</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Funda&#231;&#227;o Oswaldo Cruz</institution>
        <institution content-type="orgdiv1">Escola Nacional de Sa&#250;de P&#250;blica </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>12</month>
        <year>2011</year>
      </pub-date>
      <volume>97</volume>
      <issue>6</issue>
      <fpage>526</fpage>
      <lpage>540</lpage>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>01</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>11</day>
          <month>01</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>03</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>S&#237;ndrome coronariana aguda</kwd>
        <kwd>qualidade de vida</kwd>
        <kwd>perfil de impacto da doen&#231;a</kwd>
        <kwd>revis&#227;o</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>16</day>
        <month>01</month>
        <year>2012</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>ARTIGO DE REVIS&#195;O</bold>
    </p>
    <p>
      <bold>Avalia&#231;&#227;o da qualidade de vida ap&#243;s s&#237;ndrome coronariana aguda: revis&#227;o sistem&#225;tica</bold>
    </p>
    <p>
      <bold>Suzana Alves da Silva<sup>I,II,III</sup>; Sonia Regina Lambert Passos<sup>IV</sup>; Mariana Teixeira Carballo<sup>III</sup>; Mabel Figueir&#243;<sup>III</sup>; Investigadores<sup>II,V</sup></bold>
    </p>
    <p><sup>I</sup>Escola Nacional de Sa&#250;de P&#250;blica - ENSP - Fiocruz, Rio de Janeiro - RJ, Brasil </p>
    <p><sup>II</sup>PROCEP Centro de Ensino e Pesquisa, Rio de Janeiro - RJ, Brasil </p>
    <p><sup>III</sup>Hospital do Cora&#231;&#227;o - IEP - Hcor, Rio de Janeiro - RJ, Brasil </p>
    <p><sup>IV</sup>Instituto de Pesquisa Cl&#237;nica Evandro Chagas - IPEC - Fiocruz, Rio de Janeiro - RJ, Brasil </p>
    <p><sup>V</sup>Secretaria Municipal de Sa&#250;de e Defesa Civil - SMSDC-RJ, Rio de Janeiro - RJ, Brasil</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTOS:</bold> Qualidade de vida (QV) tem sido apontada como um desfecho de grande import&#226;ncia na avalia&#231;&#227;o da magnitude do benef&#237;cio de diferentes interven&#231;&#245;es terap&#234;uticas. Entretanto avalia&#231;&#227;o adequada da QV est&#225; atrelada a escolha do instrumento e aos aspectos culturais da popula&#231;&#227;o. </p>
    <p><bold>OBJETIVOS:</bold> Identificar instrumentos traduzidos para o portugu&#234;s que foram utilizados para mensurar a QV de pacientes com s&#237;ndrome coronariana aguda (SCA) segundo o tempo decorrido desde o diagn&#243;stico. </p>
    <p><bold>M&#201;TODOS:</bold> Revis&#227;o sistem&#225;tica e meta-an&#225;lise. Foram pesquisadas refer&#234;ncias em bases de dados eletr&#244;nicas, bancos de teses e disserta&#231;&#245;es e em refer&#234;ncias cruzadas. S&#227;o descritas as caracter&#237;sticas dos estudos selecionados, vari&#225;veis cl&#237;nicas e s&#243;cio-demogr&#225;ficas. Os desfechos inclu&#237;ram os escores de QV e as propriedades psicom&#233;tricas dos instrumentos validados na l&#237;ngua portuguesa (validade, confiabilidade, sensibilidade, responsividade e interpretabilidade). </p>
    <p><bold>RESULTADOS:</bold> Foram selecionados dezoito estudos, dos quais quatro foram inclu&#237;dos nas meta-an&#225;lises. As propriedades psicom&#233;tricas do question&#225;rio MacNew foram consistentemente mais elevadas do que as dos question&#225;rios WHOQOL e SF-36, principalmente para o escore social. Considerando os quatro estudos longitudinais, observou-se um aumento m&#233;dio significativo de 0,55 pontos nos escores de QV do question&#225;rio de MacNew e de 5,8 pontos nos escores do SF-36. </p>
    <p><bold>CONCLUS&#195;O:</bold> Houve melhora da QV com o tempo, mas os estudos s&#227;o restritos a apenas duas regi&#245;es do Brasil e de Portugal, poucos foram longitudinais e n&#227;o caracterizaram de forma adequada a gravidade cl&#237;nica dos pacientes e o tempo decorrido entre o diagn&#243;stico e a aplica&#231;&#227;o dos question&#225;rios. Estudos futuros s&#227;o necess&#225;rios para elucidar tais quest&#245;es.</p>
    <p><bold>Palavras-chave:</bold> S&#237;ndrome coronariana aguda, qualidade de vida, perfil de impacto da doen&#231;a, revis&#227;o.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>O Infarto Agudo do Mioc&#225;rdio (IAM) &#233; mundialmente conhecido, desde os prim&#243;rdios do s&#233;culo XX, como uma doen&#231;a quase sempre fatal. O impacto f&#237;sico e psicoemocional provocado pela doen&#231;a e a elevada preval&#234;ncia de depress&#227;o t&#234;m sido apontados como os principais fatores que contribuem para o preju&#237;zo da qualidade de vida (QV) desses pacientes em m&#233;dio e em longo prazo<sup>1-3</sup>.</p>
    <p>Uma revis&#227;o sistem&#225;tica de estudos que avaliaram QV ap&#243;s infarto agudo do mioc&#225;rdio demonstrou que os efeitos do infarto sobre a QV se dissipam em longo prazo, mas avalia&#231;&#227;o espec&#237;fica de pacientes que evoluem com comprometimento da fun&#231;&#227;o ventricular esquerda, na fase aguda do evento, n&#227;o parece ter sido realizada<sup>4</sup>. Al&#233;m disso, dois estudos indicam que as consequ&#234;ncias tanto da doen&#231;a coronariana isqu&#234;mica cr&#244;nica quanto da insufici&#234;ncia card&#237;aca n&#227;o s&#227;o tempor&#225;rias, e seus efeitos na mensura&#231;&#227;o da QV pioram logo ap&#243;s o diagn&#243;stico, sem apresentar melhora no acompanhamento dos pacientes, de forma diferente do que tem sido relatado ap&#243;s um evento agudo<sup>4,5</sup>.</p>
    <p>Embora os sistemas de sa&#250;de sempre enfatizem o controle da morbidade e da mortalidade, preocupa&#231;&#245;es mais recentes tamb&#233;m t&#234;m estimulado a avalia&#231;&#227;o do impacto provocado pelos agravos de sa&#250;de na vida di&#225;ria dos pacientes. Habitualmente estas quantifica&#231;&#245;es s&#227;o feitas atrav&#233;s de question&#225;rios desenvolvidos e validados atrav&#233;s de metodologia espec&#237;fica, que envolve sua replica&#231;&#227;o em outras popula&#231;&#245;es que n&#227;o a popula&#231;&#227;o original no qual foram desenvolvidos.</p>
    <p>S&#227;o in&#250;meros os instrumentos para avaliar a QV em pacientes com cardiopatia isqu&#234;mica e metodologias espec&#237;ficas foram desenvolvidas para tradu&#231;&#227;o, adapta&#231;&#227;o cultural e interpreta&#231;&#227;o dos instrumentos quando aplicados em outros idiomas. Esta revis&#227;o sistem&#225;tica tem por objetivo analisar quais instrumentos traduzidos para a l&#237;ngua portuguesa foram utilizados para avaliar a qualidade de vida em pacientes com s&#237;ndrome coronariana aguda (SCA) e a interpreta&#231;&#227;o dos seus resultados de acordo com as propriedades psicom&#233;tricas dos mesmos.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>
      <bold>Estrat&#233;gia de busca</bold>
    </p>
    <p>A pesquisa bibliogr&#225;fica foi realizada por bibliotec&#225;ria especializada na &#225;rea de ci&#234;ncias m&#233;dicas e salva em software de gerenciamento de refer&#234;ncias (Endnote vers&#227;o 13.0). A busca n&#227;o foi restrita para idioma ou per&#237;odos. Os portais, respectivas bases e sintaxes utilizadas est&#227;o descritas na <xref ref-type="table" rid="a13tab01m">Tabela 1</xref>. Foi realizada busca manual de refer&#234;ncias cruzadas relevantes.</p>
    <p content-type="asset">
      <table-wrap id="a13tab01m">
        <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt01.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Crit&#233;rios de sele&#231;&#227;o das refer&#234;ncias e extra&#231;&#227;o dos dados</bold>
    </p>
    <p>A sele&#231;&#227;o das refer&#234;ncias e a coleta de informa&#231;&#245;es foi realizada segundo o <italic>guideline</italic> Prisma<sup>6</sup>, por duplas de pesquisadores treinados independentes. A sele&#231;&#227;o das refer&#234;ncias foi feita atrav&#233;s da leitura dos resumos oriundos da pesquisa bibliogr&#225;fica (<xref ref-type="table" rid="a13tab01m">tabela 1</xref>) e a extra&#231;&#227;o de dados realizada atrav&#233;s da leitura do texto completo das refer&#234;ncias selecionadas para as vari&#225;veis de interesse.</p>
    <p>Foram inclu&#237;dos na an&#225;lise todos os estudos que avaliaram a qualidade de vida de pacientes com diagn&#243;stico de s&#237;ndrome coronariana aguda ou infarto agudo do mioc&#225;rdio, utilizando instrumentos traduzidos para o idioma portugu&#234;s.</p>
    <p>Os estudos foram inclu&#237;dos na an&#225;lise independentemente do delineamento e da extens&#227;o do acompanhamento. Estudos com resultados fora dos limites de varia&#231;&#227;o das escalas foram exclu&#237;dos.</p>
    <p>
      <bold>Vari&#225;veis selecionadas e desfechos de interesse</bold>
    </p>
    <p>Foram analisados os desfechos de qualidade de vida definidos como os escores total e resumidos de cada instrumento, segundo o tempo decorrido entre o diagn&#243;stico da s&#237;ndrome coronariana aguda e a aplica&#231;&#227;o do instrumento e de acordo com as caracter&#237;sticas cl&#237;nicas e o perfil s&#243;cio-demogr&#225;fico da popula&#231;&#227;o inclu&#237;da na an&#225;lise. Os resultados de validade, compreendendo validade de crit&#233;rio (sensibilidade, especificidade, raz&#227;o de verossimilhan&#231;a) e de construto (coeficientes de correla&#231;&#227;o de Pearson, Spearman ou Kendall); confiabilidade, compreendendo consist&#234;ncia interna (Teste alfa de Cronbach) e reprodutibilidade (Coeficiente de Correla&#231;&#227;o Intra-Classe ou Kappa ponderado), bem como sensibilidade, responsividade e interpretabilidade foram pesquisados e apenas os resultados encontrados foram descritos.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>As refer&#234;ncias selecionadas bem como os dados coletados foram cadastrados em base de dados ACCESS vers&#227;o 2007, constru&#237;da especificamente para este fim.</p>
    <p>Vari&#225;veis quantitativas foram sumarizadas por m&#233;dias e desvios-padr&#227;o como m&#233;trica dos escores de qualidade de vida e das propriedades psicom&#233;tricas dos instrumentos avaliados. A heterogeneidade entre os estudos foi avaliada com base no Teste Cochrane Q<sup>2</sup> com n&#237;vel de signific&#226;ncia de 10%<sup>7</sup>. O Teste I<sup>2</sup> tamb&#233;m foi utilizado para quantificar a heterogeneidade entre os estudos numa escala de 0 a 100%. Estudos com I<sup>2</sup>&gt; 75% foram considerados altamente heterog&#234;neos. A combina&#231;&#227;o dos resultados foi realizada utilizando as m&#233;dias e os desvios-padr&#227;o dos estudos considerando a m&#233;dia ponderada pelo tamanho da amostra de acordo com metodologia padronizada pela Cochrane<sup>8</sup>. Dados dos estudos longitudinais foram consolidados por um modelo de efeitos aleat&#243;rios que considerou o Inverso da Vari&#226;ncia como medida de pondera&#231;&#227;o para comparar os resultados antes e depois em rela&#231;&#227;o ao momento de aplica&#231;&#227;o dos question&#225;rios. Este momento foi definido em rela&#231;&#227;o ao diagn&#243;stico da SCA e estratificado em: <underline>&lt;</underline> 2 meses e &gt; 2 meses e comparados entre si. Para os estudos seccionais, a compara&#231;&#227;o entre os dois momentos foi feita considerando dados imputados da m&#233;dia ponderada dos demais estudos naquele per&#237;odo (antes ou depois).</p>
    <p>Os testes estat&#237;sticos foram realizados no programa RevMan 5 (Cochrane), considerando um n&#237;vel de signific&#226;ncia de 5%. Todos os testes foram bicaudais.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>
      <bold>Sele&#231;&#227;o das refer&#234;ncias e caracter&#237;sticas dos estudos inclu&#237;dos</bold>
    </p>
    <p>Os resultados da estrat&#233;gia de busca e sele&#231;&#227;o de refer&#234;ncias est&#227;o descritos na <xref ref-type="fig" rid="a13fig01m">figura 1</xref> e as caracter&#237;sticas dos estudos selecionados na <xref ref-type="table" rid="a13tab01m">tabela 1</xref>. Foram localizadas quatro revis&#245;es<sup>9-12</sup> que serviram de base para busca de refer&#234;ncias cruzadas.</p>
    <p content-type="asset">
      <fig id="a13fig01m">
        <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gf01.jpg"/></fig>
    </p>
    <p>Dos 2.990 resumos revisados, dezoito textos completos foram inclu&#237;dos na s&#237;ntese qualitativa dos quais: tr&#234;s coortes<sup>13-15</sup>, dois casos-controles<sup>16,17</sup>, onze seccionais<sup>18-28</sup>, um ensaio cl&#237;nico n&#227;o randomizado<sup>29</sup> e um ensaio cl&#237;nico randomizado<sup>30</sup>. Foram exclu&#237;dos tr&#234;s resumos cujos textos completos n&#227;o foram publicados<sup>31-33</sup> e duas publica&#231;&#245;es com dados dos mesmos pacientes de outros dois estudos inclu&#237;dos na an&#225;lise<sup>34,35</sup>. Um n&#250;mero expressivo de perdas foi observado em sete dos dezoito estudos inclu&#237;dos. Tr&#234;s estudos, um sobre o Seattle<sup>15</sup>, um sobre IPQ (do ingl&#234;s, Illness Perception Questionnaire)<sup>28</sup> e um sobre NHP (do ingl&#234;s, Nothinghan Health Profile)<sup>16</sup>, os &#250;nicos a empregar estes instrumentos, n&#227;o foram inclu&#237;dos na s&#237;ntese quantitativa. Quatro estudos contribu&#237;ram para a meta-an&#225;lise (<xref ref-type="fig" rid="a13fig01m">figura 1</xref>).</p>
    <p>A qualidade de vida p&#243;s-SCA foi avaliada em popula&#231;&#245;es selecionadas do sul e sudeste do Brasil, bem como dos distritos do Porto e de Coimbra em Portugal, a grande maioria de pacientes atendidos em ambulat&#243;rios de cardiologia ou programas de reabilita&#231;&#227;o de hospitais universit&#225;rios (<xref ref-type="table" rid="a13tab02m">tabela 2</xref>).</p>
    <p content-type="asset">
      <table-wrap id="a13tab02m">
        <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt02.jpg"/></table-wrap>
    </p>
    <p>A sele&#231;&#227;o de pacientes nestes estudos foi feita atrav&#233;s de busca nos registros de prontu&#225;rio ou de cadastro no hospital e o tamanho da amostra foi definido por conveni&#234;ncia. O tempo decorrido desde o diagn&#243;stico da SCA e a aplica&#231;&#227;o do question&#225;rio variou entre os estudos e n&#227;o est&#225; claro em dois deles. Em sete estudos o tempo foi inferior a dois meses e em nove variou de dois meses &#224; doze anos. O m&#233;todo de aplica&#231;&#227;o do question&#225;rio, se por entrevista, contato telef&#244;nico ou auto-aplica&#231;&#227;o foi descrito em apenas seis estudos, n&#227;o ficou claro em dois estudos e n&#227;o foi relatado nos demais (<xref ref-type="table" rid="a13tab02m">tabela 2</xref>).</p>
    <p>A maioria dos estudos n&#227;o informa sobre hist&#243;ria pr&#233;via, h&#225;bitos, com exce&#231;&#227;o de tabagismo, e caracter&#237;sticas s&#243;cio-demogr&#225;ficas das popula&#231;&#245;es estudadas (<xref ref-type="table" rid="a13tab03m">tabela 3</xref>). Nenhum dos estudos selecionados ajustou seus resultados para qualquer destas caracter&#237;sticas. A renda familiar foi inferior a quatro sal&#225;rios m&#237;nimos<sup>19,25,26,28</sup> e a escolaridade inferior a quatro anos em mais de 50% da popula&#231;&#227;o estudada, com exce&#231;&#227;o do estudo de Dias e cols.<sup>13</sup> que excluiu pacientes com baixa escolaridade. Apenas dois estudos descreveram o percentual de pacientes que retornaram ao trabalho ap&#243;s o evento coronariano, variando de 26%<sup>19</sup> a 52%<sup>28</sup>.</p>
    <p content-type="asset">
      <table-wrap id="a13tab03m">
        <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt03.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Question&#225;rios de Qualidade de Vida</bold>
    </p>
    <p>Os question&#225;rios de qualidade de vida mais amplamente utilizados foram: SF-36, em nove estudos; MacNew, em seis estudos; WHOQOL, em tr&#234;s deles e Seattle, IPQ e NHP em um estudo cada. Os escores resumidos e globais obtidos nos per&#237;odos antes e ap&#243;s dois meses, bem como a m&#233;dia da diferen&#231;a nos dois momentos, s&#227;o apresentados para os question&#225;rios SF-36 e MacNew nas <xref ref-type="fig" rid="a13fig02m">figuras 2</xref> e <xref ref-type="fig" rid="a13fig03m">3</xref>, respectivamente, tanto para os estudos seccionais quanto para os longitudinais. As duas meta-an&#225;lises realizadas para os estudos longitudinais demonstram melhora da qualidade de vida no seguimento tardio, de 0,55(IC95% 0,34-0,76) para o question&#225;rio de MacNew e de 5,87(IC95% 3,42-8,31) para o SF-36, em compara&#231;&#227;o com o acompanhamento inicial, de at&#233; dois meses ap&#243;s o diagn&#243;stico da SCA.</p>
    <p content-type="asset">
      <fig id="a13fig02m">
        <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gf02.jpg"/></fig>
    </p>
    <p content-type="asset">
      <fig id="a13fig03m">
        <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gf03.jpg"/></fig>
    </p>
    <p>As m&#233;dias ponderadas do SF36, MacNew e WHOQOL<sup>36</sup> bem como os resultados do Seattle observados no estudo de Souza e cols.<sup>15</sup>, foram semelhantes aos observados em pacientes com s&#237;ndrome coronariana aguda em outros pa&#237;ses (<xref ref-type="table" rid="a13tab04m">tabela 4</xref>)<sup>37-40</sup>, e inferiores aos escores observados na popula&#231;&#227;o geral dos Estados Unidos e de outros pa&#237;ses (<xref ref-type="table" rid="a13tab04m">tabela 4</xref>)<sup>41</sup>, exceto para as medidas resumidas que tiveram um comportamento mais parecido com o da popula&#231;&#227;o geral de outros pa&#237;ses do que com o da popula&#231;&#227;o com SCA<sup>42</sup>.</p>
    <p content-type="asset">
      <table-wrap id="a13tab04m">
        <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt04.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Propriedades Psicom&#233;tricas</bold>
    </p>
    <p>As propriedades psicom&#233;tricas dos question&#225;rios MacNew, WHOQOL e SF36 foram avaliadas em quatro dos dezoito estudos analisados. <underline>Validade de construto do tipo convergente</underline> foi analisada atrav&#233;s da correla&#231;&#227;o de Pearson entre os question&#225;rios MacNew, doen&#231;a-espec&#237;fico, e SF-36, geral (Alc&#226;ntara<sup>25</sup>, Leal e cols.<sup>14</sup> e Nakajima e cols.<sup>19</sup>), e entre os question&#225;rios WHOQOL-breve e SF-36, ambos gerais (Cruz e cols.<sup>26</sup>).</p>
    <p>As correla&#231;&#245;es entre os escores do MacNew e do SF-36 foram &gt; 0,6 para os escores sa&#250;de mental, vitalidade e capacidade funcional.19 O escore emocional do MacNew apresentou correla&#231;&#227;o &gt; 0,6 apenas com dois dom&#237;nios do SF-36: sa&#250;de mental (r = 0,78) e vitalidade (r = 0,69).19,25. As correla&#231;&#245;es entre o componente f&#237;sico do SF-36 e os escores global e f&#237;sico do MacNew foram de 0,70 e 0,72, respectivamente, e entre o componente mental do SF-36 e o escore emocional do MacNew, foi de 0,78 (Leal e cols.<sup>14</sup>). A correla&#231;&#227;o entre os escores emocionais dos dois question&#225;rios variou de -0,15 (Alc&#226;ntara e cols.<sup>25</sup>) a 0,45 (Nakajima e cols.<sup>19</sup>) e entre os escores sociais variou de 0,49 a 0,58 entre os estudos<sup>14,19,25</sup>. Leal e cols.<sup>14</sup> observaram correla&#231;&#245;es significativas (r &gt; 0,70) entre os escores globais e resumidos de ambos os question&#225;rios dentro das mesmas dimens&#245;es (componente f&#237;sico do SF-36 vs. escore global e escore f&#237;sico do MacNew e componente mental do SF-36 vs. escore emocional do MacNew). Cruz e cols.<sup>26</sup> encontraram correla&#231;&#227;o de Pearson significativa (r &gt; 0,55) entre o escore f&#237;sico do WHOQOL e todos os escores do SF-36 (exceto para os escores limita&#231;&#227;o f&#237;sica e estado emocional) e entre o escore psicol&#243;gico do WHOQOL e os escores de sa&#250;de mental e vitalidade do SF-36. Os escores vitalidade (r = 0,58) e sa&#250;de mental do SF-36 (r = 0,68) e todos os escores do question&#225;rio WHOQOL (r &gt; 0,55) se correlacionaram moderadamente com o question&#225;rio de depress&#227;o de Beck<sup>26</sup>.</p>
    <p><underline>Validade de construto do tipo discriminante</underline> foi investigada nos estudos de Nakajima e cols.<sup>19</sup> e de Leal e cols.<sup>14</sup>. Pacientes com disfun&#231;&#227;o ventricular grave apresentaram escores de qualidade de vida significativamente mais baixos comparado aos com disfun&#231;&#227;o ventricular leve ou moderada<sup>19</sup>. O question&#225;rio de MacNew foi capaz de discriminar significativamente pacientes com disfun&#231;&#227;o grave do ventr&#237;culo esquerdo dos demais, bem como pacientes com piora evolutiva nos escores do question&#225;rio SF-36 daqueles com melhora ou sem mudan&#231;a nestes escores. O question&#225;rio de MacNew tamb&#233;m foi capaz de discriminar pacientes com e sem depress&#227;o ou ansiedade pelas escala hospitalar de ansiedade e depress&#227;o<sup>14</sup>.</p>
    <p>A <underline>consist&#234;ncia interna </underline>(&#945;-Cronbach) do SF-36 e do WHOQOL, avaliada por Cruz e cols.<sup>26</sup>, foi &gt; 0,7 para todas as dimens&#245;es exceto escore social. Nos estudos de Nakajima e cols.<sup>19</sup> e Leal e cols.<sup>14</sup>, que avaliaram o question&#225;rio de MacNew, a consist&#234;ncia interna foi &gt;0,8 para todas as dimens&#245;es. Estes resultados s&#227;o semelhantes ao que foi observado em outros pa&#237;ses (<xref ref-type="table" rid="a13tab05m">tabela 5</xref>)<sup>43-46</sup>.</p>
    <p content-type="asset">
      <table-wrap id="a13tab05m">
        <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt05.jpg"/></table-wrap>
    </p>
    <p>A <underline>reprodutibilidade</underline> foi avaliada exclusivamente por Leal e cols.<sup>14</sup> atrav&#233;s da correla&#231;&#227;o intra-classe do teste-reteste para o question&#225;rio de MacNew, com resultados variando de 0,77 a 0,93, tamb&#233;m com resultados parecidos com os de outros pa&#237;ses (<xref ref-type="table" rid="a13tab05m">tabela 5</xref>)<sup>44</sup>.</p>
    <p>O <underline>efeito piso-teto</underline>, presente quando acima de 10%<sup>47</sup>, foi observado nos escores "estado emocional" e "limita&#231;&#227;o f&#237;sica" do SF-36 avaliado no estudo de Cruz e cols.<sup>26</sup>. Este efeito n&#227;o esteve presente no question&#225;rio de MacNew avaliado no estudo de Leal e cols.<sup>14</sup>.</p>
    <p>
      <bold>Heterogeneidade</bold>
    </p>
    <p>Os estudos longitudinais inclu&#237;dos nas meta-an&#225;lises apresentaram heterogeneidade moderada. Meta-regress&#227;o para avalia&#231;&#227;o das causas da heterogeneidade n&#227;o foi realizada devido &#224; aus&#234;ncia e inconsist&#234;ncia das informa&#231;&#245;es na maioria dos estudos. Poss&#237;veis causas de heterogeneidade podem estar relacionadas aos diferentes desenhos de estudos inclu&#237;dos na an&#225;lise e aos m&#233;todos utilizados para sele&#231;&#227;o dos sujeitos de pesquisa e aplica&#231;&#227;o do question&#225;rio. Outra poss&#237;vel fonte de heterogeneidade foi o tempo decorrido entre a s&#237;ndrome coronariana aguda e o momento de aplica&#231;&#227;o do question&#225;rio principalmente no grupo classificado como avalia&#231;&#227;o "&gt; 2 meses", que variou de tr&#234;s meses a seis anos desde o diagn&#243;stico. Al&#233;m disso, para os estudos seccionais, alguns dados foram imputados com base na m&#233;dia ponderada dos demais estudos dentro da mesma categoria, de forma que a compara&#231;&#227;o das m&#233;dias antes e depois pudesse ser realizada para os estudos encontrados. As caracter&#237;sticas cl&#237;nicas e s&#243;cio-demogr&#225;ficas, quando relatadas, tamb&#233;m variaram bastante entre os estudos e parecem homog&#234;neas apenas para a faixa et&#225;ria e sexo (<xref ref-type="table" rid="a13tab03m">tabela 3</xref>).</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Esta revis&#227;o sistem&#225;tica faz um levantamento do que foi produzido no Brasil e em Portugal em rela&#231;&#227;o ao tema "qualidade de vida" na coronariopatia aguda, levando em considera&#231;&#227;o os resultados dos escores de qualidade de vida por diferentes instrumentos, de acordo com o tempo de doen&#231;a e com as suas propriedades psicom&#233;tricas.</p>
    <p>As propriedades psicom&#233;tricas dos instrumentos foram avaliadas em apenas quatro dos dezoito estudos analisados, tr&#234;s dos quais avaliaram a associa&#231;&#227;o de um question&#225;rio geral (SF-36) a um question&#225;rio espec&#237;fico (MacNew) e s&#227;o discutidas abaixo.</p>
    <p>
      <bold>Validade de construto</bold>
    </p>
    <p>A validade de construto foi avaliada de acordo com m&#233;todos previamente estabelecidos<sup>48,49</sup> e demonstrou: 1) elevada converg&#234;ncia entre os itens do question&#225;rio MacNew e SF-36,considerando o mesmo construto, exceto para os escores emocionais, provavelmente porque estes medem diferentes aspectos da qualidade de vida. Enquanto o MacNew se preocupa com a percep&#231;&#227;o do paciente o SF-36 se preocupa com o impacto do estado emocional nas suas atividades di&#225;rias; 2) elevada converg&#234;ncia foi observada entre todas as dimens&#245;es do WHOQOL-breve e apenas o escore de sa&#250;de mental do SF-36,mas n&#227;o entre os demais escores deste instrumento, provavelmente um reflexo do fato de que os dois question&#225;rios apresentam escopos bem diferentes. Enquanto o SF-36 foi elaborado para avaliar estados de sa&#250;de, o WHOQOL foi elaborado para avaliar a percep&#231;&#227;o do paciente com rela&#231;&#227;o aos diferentes aspectos de sua vida, de uma forma global; 3) baixa capacidade discriminante dos question&#225;rios gerais em contra-posi&#231;&#227;o a boa capacidade discriminante do question&#225;rio espec&#237;fico MacNew para mudan&#231;as na qualidade de vida relacionadas a sintomas de insufici&#234;ncia card&#237;aca ou depress&#227;o e 4) moderada capacidade discriminante do question&#225;rio WHOQOL para presen&#231;a de depress&#227;o.</p>
    <p>As an&#225;lises de validade de construto do tipo discriminante se restringiram ao question&#225;rio de MacNew que evidenciou boa capacidade de discrimina&#231;&#227;o entre pacientes com e sem disfun&#231;&#227;o ventricular grave, depress&#227;o e ansiedade comparado a observa&#231;&#245;es longitudinais com o SF-36 As classes funcionais de angina ou insufici&#234;ncia card&#237;aca n&#227;o foram avaliadas, mas estudos pr&#233;vios sugerem que estes question&#225;rios t&#234;m baixa propriedade discriminante para estes itens<sup>3</sup>.</p>
    <p>Validade de crit&#233;rio n&#227;o foi avaliada em nenhum dos estudos inclu&#237;dos nesta revis&#227;o e sua import&#226;ncia se relacionaria a determina&#231;&#227;o da acur&#225;cia principalmente dos instrumentos espec&#237;ficos para defini&#231;&#227;o da presen&#231;a ou aus&#234;ncia de condi&#231;&#245;es cl&#237;nicas de interesse tais como re-obstru&#231;&#227;o coronariana ou insufici&#234;ncia card&#237;aca durante o acompanhamento cl&#237;nico desses pacientes.</p>
    <p>
      <bold>Confiabilidade</bold>
    </p>
    <p>A consist&#234;ncia interna avaliada pelo alfa de Cronbach foi baixa para o escore social dos question&#225;rios gerais tanto do SF-36 quanto do WHOQOL, enquanto que os question&#225;rios espec&#237;ficos MacNew e Seattle se comportaram de forma diferente dos question&#225;rios gerais e apresentaram consist&#234;ncia interna elevada em todas as suas dimens&#245;es.</p>
    <p>A reprodutibilidade, considerada satisfat&#243;ria quando acima de 0,50 para compara&#231;&#227;o entre grupos e acima de 0,90 para avalia&#231;&#227;o do indiv&#237;duo com ele mesmo<sup>44,47</sup>, foi avaliada apenas para o question&#225;rio MacNew em um dos estudos, demonstrando que este question&#225;rio apresentou elevada confiabilidade na popula&#231;&#227;o estudada<sup>14</sup>.</p>
    <p>
      <bold>Sensibilidade</bold>
    </p>
    <p>As dimens&#245;es do SF-36 que contemplam o estado emocional e a fun&#231;&#227;o social evidenciaram efeito-piso teto elevado, que tamb&#233;m esteve presente de forma moderada nas dimens&#245;es dor corporal e limita&#231;&#227;o f&#237;sica, compat&#237;vel com o observado em estudos pr&#233;vios<sup>45,46</sup>. A propens&#227;o ao efeito piso-teto foi baixa para os question&#225;rios espec&#237;ficos de MacNew e de Seattle. Embora o efeito piso-teto tenha sido descrito como um bom par&#226;metro para inferir a sensibilidade de instrumentos de qualidade de vida, uma vez que demonstra se o instrumento &#233; capaz de detectar varia&#231;&#245;es outras entre os indiv&#237;duos que n&#227;o os extremos da medida, &#233; um m&#233;todo considerado por muitos autores insuficiente para avaliar se o instrumento &#233; capaz de detectar pequenas diferen&#231;as<sup>50</sup>. O m&#233;todo que tem sido proposto para avalia&#231;&#227;o desta propriedade &#233; o da magnitude de efeito entre os grupos por meio de testes estat&#237;sticos espec&#237;ficos, tais como o tamanho de efeito de Cohen, o &#237;ndice de responsividade de Guyatt e a m&#233;dia padronizada da diferen&#231;a, o que n&#227;o foi feito em nenhum dos estudos analisados<sup>50,51</sup>.</p>
    <p>
      <bold>Responsividade</bold>
    </p>
    <p>A interpreta&#231;&#227;o na mudan&#231;a dos escores de qualidade de vida com o tempo &#233; outra quest&#227;o de alta relev&#226;ncia no acompanhamento de pacientes com cardiopatia isqu&#234;mica<sup>52</sup>. O efeito piso-teto tamb&#233;m tem sido utilizado como um indicador &#250;til de responsividade do instrumento<sup>50</sup>, mas o conceito mais amplamente utilizado na literatura &#233; o da "Diferen&#231;a M&#237;nima que Importa", (MID, do ingl&#234;s "<italic>minimal important difference</italic>") que representa a menor diferen&#231;a no escore do dom&#237;nio de interesse que &#233; percebida pelo paciente e que determinaria, na aus&#234;ncia de limita&#231;&#245;es cl&#237;nicas ou financeiras, mudan&#231;a na conduta terap&#234;utica do paciente<sup>53,54</sup>. Norman e cols.<sup>54</sup>, com base em uma revis&#227;o sistem&#225;tica de estudos de qualidade de vida, demonstraram que a MID pode ser estimada com base na &#189; do desvio padr&#227;o da m&#233;dia dos escores resultante da aplica&#231;&#227;o inicial do instrumento naquela popula&#231;&#227;o<sup>54</sup>. Tem sido demonstrado que uma mudan&#231;a de no m&#237;nimo 0,5 e 3,5 s&#227;o indicadores &#250;teis para MID nos escores dos question&#225;rios MacNew e Seattle, respectivamente<sup>55,56</sup>. Para o question&#225;rio SF-36 uma varia&#231;&#227;o em torno de 10 pontos para os escores individuais representou uma mudan&#231;a acentuada na percep&#231;&#227;o de sa&#250;de dos pacientes, enquanto que uma mudan&#231;a em torno de cinco pontos representou uma mudan&#231;a moderada<sup>57</sup>. Nesta revis&#227;o apenas quatro dos dezoito estudos encontrados permitiram esta an&#225;lise, com valores encontrados de 0,55 ponto para o MacNew e de 5,78 pontos para o SF-36, consistentes com o que tem sido estabelecido como MID para estes instrumentos. Uma mudan&#231;a de aproximadamente quinze pontos foi observada no &#250;nico estudo que avaliou o question&#225;rio de Seattle<sup>15</sup>. Esta grande varia&#231;&#227;o pode estar relacionada ao momento da primeira aplica&#231;&#227;o do instrumento, feito na admiss&#227;o do paciente no hospital, quando o mesmo se apresentava agudamente sintom&#225;tico<sup>15</sup>. Com exce&#231;&#227;o do question&#225;rio de Seattle, tais achados corroboram os resultados da revis&#227;o sistem&#225;tica de Simpson, que sugere que ocorre uma recupera&#231;&#227;o modesta da qualidade de vida ap&#243;s um evento coronariano agudo<sup>58</sup>.</p>
    <p>Os resultados de uma revis&#227;o sistem&#225;tica pr&#233;via, produzida por Dempster e cols.<sup>59</sup>, sugerem que os question&#225;rios gerais tais como o SF-36 e o <italic>Nothinghan Health Profile</italic> t&#234;m baixa responsividade e, portanto, seus resultados devam ser interpretados com cautela uma vez que estes instrumentos s&#227;o pouco sens&#237;veis &#224; captura de pequenas varia&#231;&#245;es evolutivas na qualidade de vida de pacientes com cardiopatia isqu&#234;mica. Al&#233;m de Dempster, outros autores t&#234;m sugerido que um question&#225;rio espec&#237;fico deva ser sempre associado a um question&#225;rio geral para avalia&#231;&#227;o da qualidade de vida de pacientes com cardiopatia isqu&#234;mica<sup>3,59</sup>.</p>
    <p>
      <bold>Valida&#231;&#227;o transcultural</bold>
    </p>
    <p>Embora os instrumentos gerais WHOQOL e SF-36 tenham sido os mais amplamente utilizados nos estudos avaliados, eles foram utilizados de forma isolada e foram validados na l&#237;ngua portuguesa em pacientes com caracter&#237;sticas cl&#237;nicas completamente diferentes daquelas apresentadas por pacientes portadores de doen&#231;a coronariana<sup>60,61</sup>. Entretanto, avalia&#231;&#245;es pr&#233;vias sugerem que pelo menos o SF-36 apresenta elevada confiabilidade em diferentes culturas e em diferentes condi&#231;&#245;es cl&#237;nicas, e no Brasil, apresentou reprodutibilidade adequada em uma popula&#231;&#227;o de pacientes com angina est&#225;vel<sup>62</sup>. Os demais instrumentos (Seattle, MacNew e NHP), doen&#231;a-espec&#237;ficos, foram validados na popula&#231;&#227;o de interesse. Embora haja registro de tradu&#231;&#227;o e valida&#231;&#227;o do question&#225;rio de Seattle para pacientes brasileiros com angina est&#225;vel, detalhes do processo de tradu&#231;&#227;o transcultural n&#227;o est&#227;o descritos<sup>62</sup>. &#201; curioso o fato de que nenhum instrumento espec&#237;fico para insufici&#234;ncia card&#237;aca tenha sido utilizado nos estudos avaliados. &#201; sabido que uma propor&#231;&#227;o significativa de pacientes evolui com insufici&#234;ncia card&#237;aca ap&#243;s um evento coronariano agudo e que informa&#231;&#245;es de qualidade de vida em pacientes que evoluem com grave disfun&#231;&#227;o ventricular no per&#237;odo inicial ap&#243;s o evento coronariano agudo s&#227;o escassas e, quando dispon&#237;veis, s&#227;o restritas aos question&#225;rios gerais.</p>
    <p>
      <bold>Limita&#231;&#245;es</bold>
    </p>
    <p>Os estudos inclu&#237;dos na meta-an&#225;lise apresentaram heterogeneidade moderada. A escassez de informa&#231;&#245;es dispon&#237;veis impediu que fossem inclu&#237;dos na an&#225;lise apenas coortes prospectivas, que demonstrassem claramente a evolu&#231;&#227;o da qualidade de vida no per&#237;odo inicial e tardio ap&#243;s um evento coronariano agudo impedindo tamb&#233;m que uma meta-regress&#227;o fosse feita para identifica&#231;&#227;o das demais causas de heterogeneidade.</p>
    <p>As avalia&#231;&#245;es de qualidade de vida n&#227;o foram ajustadas para nenhuma das vari&#225;veis cl&#237;nicas ou s&#243;cio-demogr&#225;ficas pesquisadas, que sabidamente influenciam no resultado dos escores obtidos. Os pacientes inclu&#237;dos nos estudos n&#227;o foram homog&#234;neos quanto ao tempo, gravidade da doen&#231;a e quanto as varia&#231;&#245;es culturais entre Brasil e Portugal. Al&#233;m disso, os estudos transversais inclu&#237;dos na an&#225;lise foram categorizados em avalia&#231;&#227;o precoce ou tardia, sendo que a informa&#231;&#227;o faltante foi imputada com base na m&#233;dia ponderada dos demais estudos dentro da mesma categoria. Portanto a compara&#231;&#227;o antes e depois foi feita com base na compara&#231;&#227;o de estudos e n&#227;o de grupos pareados nas figuras apresentadas, exceto para os escores resumidos do question&#225;rio SF-36. As varia&#231;&#245;es nas m&#233;dias dos escores tamb&#233;m podem estar relacionadas &#224;s interven&#231;&#245;es propostas para o tratamento dos pacientes, que n&#227;o foram avaliadas nesta an&#225;lise.</p>
    <p>Estes fatores em conjunto impedem uma interpreta&#231;&#227;o acurada do comportamento da qualidade de vida em pacientes brasileiros ou portugueses que sofrem de um evento coronariano agudo e as diferen&#231;as entre a avalia&#231;&#227;o precoce e tardia deve ser vista com cautela. Tais informa&#231;&#245;es, entretanto, podem ser &#250;teis na formula&#231;&#227;o de hip&#243;teses e na escolha do instrumento mais apropriado para avalia&#231;&#227;o destas popula&#231;&#245;es.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Apesar das limita&#231;&#245;es, esta revis&#227;o faz uma s&#237;ntese dos estudos feitos com instrumentos para avalia&#231;&#227;o de qualidade de vida, que foram traduzidos para o portugu&#234;s, demonstrando falhas nos m&#233;todos de valida&#231;&#227;o e tornando claro que informa&#231;&#245;es quanto a evolu&#231;&#227;o da qualidade de vida em pacientes brasileiros ou portugueses que sofrem um evento coronariano agudo ainda s&#227;o necess&#225;rias. Houve um aumento significativo nos escores de qualidade de vida de 0,55 ponto para o question&#225;rio de MacNew e de 5,8 pontos para o question&#225;rio SF-36. Esta revis&#227;o pode ser &#250;til para elabora&#231;&#227;o, desenho e execu&#231;&#227;o de estudos futuros nesta &#225;rea.</p>
    <p>
      <bold>Agradecimentos</bold>
    </p>
    <p> Ao Prof. Thomas M. Sakae pela pronta resposta nos contatos feitos e colabora&#231;&#227;o no fornecimento dos dados n&#227;o publicados que foram importantes para esta an&#225;lise e a Bibliotec&#225;ria Maria Eduarda Puga por sua orienta&#231;&#227;o valiosa na constru&#231;&#227;o da estrat&#233;gia de busca.</p>
    <p>
      <bold>Co-Investigadores</bold>
    </p>
    <p>Andrea Ferreira Haddad, Fabio Antonio Abrantes Tuche, Monica Amorim de Oliveira (Secretaria Municipal de Sa&#250;de e Defesa Civil / SMSDC-RJ), Paola Martins Presta, Raphael Kasuo Osugue, Renato Correa Alves Moreira, Rodrigo Mousinho (Hospital Pr&#243;-Card&#237;aco), Rodrigo de Carvalho Moreira, Karla Menezes, Sabrina Bernardez (PROCEP Centro de Ensino e Pesquisa).</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de tese de Doutorado de Suzana Alves da Silva pela Escola Nacional de Sa&#250;de P&#250;blica S&#233;rgio Arouca / Fiocruz.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Suzana Alves Silva </p>
        <p> Rua Cinco de Julho, 176 / 101 - Copacabana </p>
        <p> 22051-030 - Rio de Janeiro, RJ - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="suzana.silva@cardiol.br">suzana.silva@cardiol.br</email>, </p>
        <p>
          <email xlink:href="suzanaalvessilva@gmail.com">suzanaalvessilva@gmail.com</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 11/01/11; revisado recebido em 11/01/11; aceito em 04/03/11.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Beck CA, Joseph L, Belisle P, Pilote L. Predictors of quality of life 6 months and 1 year after acute myocardial infarction. Am Heart J. 2001;142(2):271-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Predictors of quality of life 6 months and 1 year after acute myocardial infarction</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>271</fpage>
          <lpage>9</lpage>
          <issue>2</issue>
          <volume>142</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Beck</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Joseph</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Belisle</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pilote</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Stafford L, Berk M, Jackson HJ. Are illness perceptions about coronary artery disease predictive of depression and quality of life outcomes? J Psychosom Res. 2009;66(3):211-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Are illness perceptions about coronary artery disease predictive of depression and quality of life outcomes</article-title>
          <source>J Psychosom Res</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>211</fpage>
          <lpage>20</lpage>
          <issue>3</issue>
          <volume>66</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stafford</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Berk</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Dempster M, Donnelly M. Measuring the health related quality of life of people with ischaemic heart disease. Heart. 2000;83(6):641-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Measuring the health related quality of life of people with ischaemic heart disease</article-title>
          <source>Heart</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>641</fpage>
          <lpage>4</lpage>
          <issue>6</issue>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dempster</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Donnelly</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Failde II, Soto MM. Changes in Health Related Quality of Life 3 months after an acute coronary syndrome. BMC Public Health. 2006;6:18.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Changes in Health Related Quality of Life 3 months after an acute coronary syndrome</article-title>
          <source>BMC Public Health</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>18</fpage>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Failde</surname>
              <given-names>II</given-names>
            </name>
            <name>
              <surname>Soto</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Guyatt GH. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol. 1993;22(4 Suppl A):185A-91A.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Measurement of health-related quality of life in heart failure</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>185A</fpage>
          <lpage>91A</lpage>
          <volume>22</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Guyatt</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>1006</fpage>
          <lpage>12</lpage>
          <issue>10</issue>
          <volume>62</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Moher</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Liberati</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tetzlaff</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Altman</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Deeks JJ, Higgins JPT, Altman DG. Analysing data and undertaking meta-analyses: Heterogeneity. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Southern Gate: John Wiley &amp; Sons Ltd; 2008. p. 276-82.</mixed-citation>
        <element-citation publication-type="book">
          <source>Cochrane Handbook for Systematic Reviews of Interventions</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>276</fpage>
          <lpage>82</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Deeks</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>JPT</given-names>
            </name>
            <name>
              <surname>Altman</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>JPT</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Higgins JPT, Deeks JJ. Selecting studies and collecting data. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Southern Gate: John Wiley &amp; Sons Ltd; 2008. p. 151-83.</mixed-citation>
        <element-citation publication-type="book">
          <source>Cochrane Handbook for Systematic Reviews of Interventions</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>151</fpage>
          <lpage>83</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Higgins</surname>
              <given-names>JPT</given-names>
            </name>
            <name>
              <surname>Deeks</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>JPT</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Breda D. Reabilita&#231;&#227;o card&#237;aca e qualidade de vida. Fisioter Bras. 2005;6(4):298-304.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Reabilita&#231;&#227;o card&#237;aca e qualidade de vida</article-title>
          <source>Fisioter Bras</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>298</fpage>
          <lpage>304</lpage>
          <issue>4</issue>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Breda</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Passamani ER. Unstable angina: quality of life. Circulation. 1991;83(1):342-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Unstable angina: quality of life</article-title>
          <source>Circulation</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>342</fpage>
          <lpage>4</lpage>
          <issue>1</issue>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Passamani</surname>
              <given-names>ER</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Ad&#225;nez GP. Procedimientos de construcci&#243;n y analisis de tests psicometricos. In: Wechsler SM, Guzzo RSL, eds. Avalia&#231;&#227;o psicol&#243;gica: perspectiva internacional. S&#227;o Paulo: Casa do Psic&#243;logo; 1999. p. 57-100.</mixed-citation>
        <element-citation publication-type="book">
          <source>Avalia&#231;&#227;o psicol&#243;gica: perspectiva internacional</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>57</fpage>
          <lpage>100</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Ad&#225;nez</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Wechsler</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Guzzo</surname>
              <given-names>RSL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Dougherty CM, Dewhurst T, Nichol WP, Spertus J. Comparison of three quality of life instruments in stable angina pectoris: Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index-Cardiac Version III. J Clin Epidemiol. 1998;51(7):569-75.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of three quality of life instruments in stable angina pectoris: Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index-Cardiac Version III</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>569</fpage>
          <lpage>75</lpage>
          <issue>7</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dougherty</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Dewhurst</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nichol</surname>
              <given-names>WP</given-names>
            </name>
            <name>
              <surname>Spertus</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Dias CC, Mateus P, Santos L, Mateus C, Sampaio F, Ad&#227;o L, et al. Acute coronary syndrome and predictors of quality of life. Rev Port Cardiol. 2005;24(6):819-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Acute coronary syndrome and predictors of quality of life</article-title>
          <source>Rev Port Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>819</fpage>
          <lpage>31</lpage>
          <issue>6</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dias</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Mateus</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mateus</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sampaio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ad&#227;o</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Leal A, Paiva C, Hofer S, Amado J, Gomes L, Oldridge N. Evaluative and discriminative properties of the Portuguese MacNew Heart Disease Health-related Quality of Life questionnaire. Qual Life Res. 2005;14(10):2335-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluative and discriminative properties of the Portuguese MacNew Heart Disease Health-related Quality of Life questionnaire</article-title>
          <source>Qual Life Res</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2335</fpage>
          <lpage>41</lpage>
          <issue>10</issue>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Leal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Paiva</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hofer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Amado</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Oldridge</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Souza EN, Quadros AS, Maestri R, Albarran C, Sarmento-Leite R. Predictors of quality of life change after an acute coronary event. Arq Bras Cardiol. 2008;91(4):229-35.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Predictors of quality of life change after an acute coronary event</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>229</fpage>
          <lpage>35</lpage>
          <issue>4</issue>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Souza</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Quadros</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Maestri</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Albarran</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sarmento-Leite</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Coelho R, Ramos E, Prata J, Maciel MJ, Barros H. Acute myocardial infarction: psychosocial and cardiovascular risk factors in men. J Cardiovasc Risk. 1999;6(3):157-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Acute myocardial infarction: psychosocial and cardiovascular risk factors in men</article-title>
          <source>J Cardiovasc Risk</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>157</fpage>
          <lpage>62</lpage>
          <issue>3</issue>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Coelho</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Prata</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Maciel</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Lemos C, Gottschall CAM, Pellanda LC, Muller M. Associa&#231;&#227;o entre depress&#227;o, ansiedade e qualidade de vida ap&#243;s infarto do mioc&#225;rdio. Psicologia: Teoria e Pesquisa. 2008;24(4):471-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Associa&#231;&#227;o entre depress&#227;o, ansiedade e qualidade de vida ap&#243;s infarto do mioc&#225;rdio</article-title>
          <source>Psicologia: Teoria e Pesquisa</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>471</fpage>
          <lpage>6</lpage>
          <issue>4</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lemos</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gottschall</surname>
              <given-names>CAM</given-names>
            </name>
            <name>
              <surname>Pellanda</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Lemos V, Sologuren MJJ, Sousa TC, Cravo SL. Qualidade de vida em pacientes ap&#243;s infarto agudo do mioc&#225;rdio. Rev Soc Cardiol Estado de S&#227;o Paulo. 2003;13(4, supl. A):17-26.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Qualidade de vida em pacientes ap&#243;s infarto agudo do mioc&#225;rdio</article-title>
          <source>Rev Soc Cardiol Estado de S&#227;o Paulo</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>17</fpage>
          <lpage>26</lpage>
          <issue>4</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lemos</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sologuren</surname>
              <given-names>MJJ</given-names>
            </name>
            <name>
              <surname>Sousa</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Cravo</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Nakajima KM, Rodrigues RC, Gallani MC, Alexandre NM, Oldridge N. Psychometric properties of MacNew Heart Disease Health-related Quality of Life Questionnaire: Brazilian version. J Adv Nurs. 2009;65(5):1084-94.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Psychometric properties of MacNew Heart Disease Health-related Quality of Life Questionnaire: Brazilian version</article-title>
          <source>J Adv Nurs</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>1084</fpage>
          <lpage>94</lpage>
          <issue>5</issue>
          <volume>65</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nakajima</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Gallani</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Alexandre</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Oldridge</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Siviero IMPS. Sa&#250;de mental e qualidade de vida de infartados. [Tese]. Ribeir&#227;o Preto: Departamento de Ci&#234;ncias Humanas e Enfermagem Psiqui&#225;trica, Universidade de S&#227;o Paulo; 2003.</mixed-citation>
        <element-citation publication-type="book">
          <source>Sa&#250;de mental e qualidade de vida de infartados</source>
          <person-group person-group-type="author">
            <name>
              <surname>Siviero</surname>
              <given-names>IMPS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Stocco ML, Castro CMd, Sakae TM. Avalia&#231;&#227;o da qualidade de vida um m&#234;s ap&#243;s a s&#237;ndrome coronariana aguda. Arquivos Catarinenses de Medicina. 2009;38(4):87-95.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Avalia&#231;&#227;o da qualidade de vida um m&#234;s ap&#243;s a s&#237;ndrome coronariana aguda</article-title>
          <source>Arquivos Catarinenses de Medicina</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>87</fpage>
          <lpage>95</lpage>
          <issue>4</issue>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stocco</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>CMd</given-names>
            </name>
            <name>
              <surname>Sakae</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Thomas CV, Souza ALd, Portal VL, Ruschel PP. Avalia&#231;&#227;o ambulatorial de qualidade de vida em pacientes p&#243;s infarto agudo do mioc&#225;rdio. Rev. SBPH. 2007;10(2):13-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Avalia&#231;&#227;o ambulatorial de qualidade de vida em pacientes p&#243;s infarto agudo do mioc&#225;rdio: Rev</article-title>
          <source>SBPH</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>13</fpage>
          <lpage>31</lpage>
          <issue>2</issue>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Thomas</surname>
              <given-names>CV</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>ALd</given-names>
            </name>
            <name>
              <surname>Portal</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Ruschel</surname>
              <given-names>PP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Vasconcelos CB. Qualidade de vida, ansiedade e depress&#227;o ap&#243;s infarto do mioc&#225;rdio [Tese]. Uberl&#226;ndia: Faculdade de Medicina, Universidade Federal de Uberl&#226;ndia; 2007.</mixed-citation>
        <element-citation publication-type="book">
          <source>Qualidade de vida, ansiedade e depress&#227;o ap&#243;s infarto do mioc&#225;rdio</source>
          <person-group person-group-type="author">
            <name>
              <surname>Vasconcelos</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Benetti M, Nahas MV, Rebelo FPV, Lemos LS, Carvalho T. Altera&#231;&#245;es na qualidade de vida em coronariopatas acometidos de infarto agudo do mioc&#225;rdio, submetidos a diferentes tipos de tratamento. Atividade F&#237;sica &amp; Sa&#250;de. 2001;6(3):27-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Altera&#231;&#245;es na qualidade de vida em coronariopatas acometidos de infarto agudo do mioc&#225;rdio, submetidos a diferentes tipos de tratamento</article-title>
          <source>Atividade F&#237;sica &amp; Sa&#250;de</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>27</fpage>
          <lpage>33</lpage>
          <issue>3</issue>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Benetti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nahas</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Rebelo</surname>
              <given-names>FPV</given-names>
            </name>
            <name>
              <surname>Lemos</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Alcantara E. Qualidade de vida ap&#243;s infarto agudo do mioc&#225;rdio: avalia&#231;&#227;o com os question&#225;rios Mac New QLMI e SF36. [Tese]. Uberl&#226;ndia: Faculdade de Medicina, Universidade Federal de Uberl&#226;ndia; 2005.</mixed-citation>
        <element-citation publication-type="book">
          <source>Qualidade de vida ap&#243;s infarto agudo do mioc&#225;rdio: avalia&#231;&#227;o com os question&#225;rios Mac New QLMI e SF36</source>
          <person-group person-group-type="author">
            <name>
              <surname>Alcantara</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Cruz LN, Camey SA, Fleck MP, Polanczyk CA. World Health Organization quality of life instrument-brief and Short Form-36 in patients with coronary artery disease: do they measure similar quality of life concepts? Psychol Health Med. 2009;14(5):619-28.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>World Health Organization quality of life instrument-brief and Short Form-36 in patients with coronary artery disease: do they measure similar quality of life concepts?</article-title>
          <source>Psychol Health Med</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>619</fpage>
          <lpage>28</lpage>
          <issue>5</issue>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cruz</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Camey</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Fleck</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Polanczyk</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Gallani MC, Colombo RC, Alexandre NM, Bressan-Biajone AM. [Quality of life in coronary patients]. Rev Bras Enferm. 2003;56(1):40-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quality of life in coronary patients</article-title>
          <source>Rev Bras Enferm</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>40</fpage>
          <lpage>3</lpage>
          <issue>1</issue>
          <volume>56</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gallani</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Colombo</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Alexandre</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Bressan-Biajone</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Gouvea JLV. Diferen&#231;as ao n&#237;vel do g&#234;nero na adapta&#231;&#227;o psicossocial a curto prazo no p&#243;s enfarte agudo do mioc&#225;rdio. [Tese]. Braga: Instituto de Educa&#231;&#227;o e Psicologia, Universidade do Minho; 2004.</mixed-citation>
        <element-citation publication-type="book">
          <source>Diferen&#231;as ao n&#237;vel do g&#234;nero na adapta&#231;&#227;o psicossocial a curto prazo no p&#243;s enfarte agudo do mioc&#225;rdio</source>
          <person-group person-group-type="author">
            <name>
              <surname>Gouvea</surname>
              <given-names>JLV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Benetti M, Araujo CL, Santos RZ. [Cardiorespiratory fitness and quality of life at different exercise intensities after myocardial infarction.]. Arq Bras Cardiol. 95(3):399-404.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiorespiratory fitness and quality of life at different exercise intensities after myocardial infarction</article-title>
          <source>Arq Bras Cardiol</source>
          <fpage>399</fpage>
          <lpage>404</lpage>
          <issue>3</issue>
          <volume>95</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Benetti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Araujo</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>RZ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Salvetti XM, Oliveira JA, Servantes DM, de Paola AAV. How much do the benefits cost? Effects of a home-based training programme on cardiovascular fitness, quality of life, programme cost and adherence for patients with coronary disease. Clin Rehabil. 2008;22(10-11):987-96.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>How much do the benefits cost: Effects of a home-based training programme on cardiovascular fitness, quality of life, programme cost and adherence for patients with coronary disease</article-title>
          <source>Clin Rehabil</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>987</fpage>
          <lpage>96</lpage>
          <issue>10-11</issue>
          <volume>22</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Salvetti</surname>
              <given-names>XM</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Servantes</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>de Paola</surname>
              <given-names>AAV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Almeida P, Miranda F, Silva P, Gon&#231;alves H, Ribeiro J, Raio J, et al. The effects of a cardiac rehabilitation program on 2 populations of coronary patients: acute myocardial infarct and coronary bypass surgery. Rev Port Cardiol. 1997;16(10):767-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effects of a cardiac rehabilitation program on 2 populations of coronary patients: acute myocardial infarct and coronary bypass surgery</article-title>
          <source>Rev Port Cardiol</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>767</fpage>
          <lpage>72</lpage>
          <issue>10</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Almeida</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Miranda</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gon&#231;alves</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Raio</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Benetti M, Nahas MV, Barros MVG. Reproducibility and validity of a brazilian version of the macnew quality of life after myocardial infarction (Macnew Qlmi) questionnaire. Med Sci Sports Exerc. 2001;33(5):S62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Reproducibility and validity of a brazilian version of the macnew quality of life after myocardial infarction (Macnew Qlmi) questionnaire</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>S62</fpage>
          <issue>5</issue>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Benetti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nahas</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>MVG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Coelho R. Factores de risco psico-social e enfarte agudo do miocardio. Nascer e Crescer. 2000;9(4):S286-94.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Factores de risco psico-social e enfarte agudo do miocardio</article-title>
          <source>Nascer e Crescer</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>S286</fpage>
          <lpage>94</lpage>
          <issue>4</issue>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Coelho</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Bettencourt N, Dias C, Mateus P, Sampaio F, Santos L, Ad&#227;o L, et al. Impact of cardiac rehabilitation on quality of life and depression after acute coronary syndrome. Rev Port Cardiol. 2005;24(5):819-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impact of cardiac rehabilitation on quality of life and depression after acute coronary syndrome</article-title>
          <source>Rev Port Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>819</fpage>
          <lpage>31</lpage>
          <issue>5</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bettencourt</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Dias</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mateus</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sampaio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ad&#227;o</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Alcantara EC, Resende ES, Paula LKGd, Silveira LC, Costa MDd. Avalia&#231;&#227;o da qualidade de vida ap&#243;s infarto agudo do mioc&#225;rdio e sua correla&#231;&#227;o com o fator de risco hipertens&#227;o arterial. Rev Bras Hipertens. 2007;14(2):118-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Avalia&#231;&#227;o da qualidade de vida ap&#243;s infarto agudo do mioc&#225;rdio e sua correla&#231;&#227;o com o fator de risco hipertens&#227;o arterial</article-title>
          <source>Rev Bras Hipertens</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>118</fpage>
          <lpage>20</lpage>
          <issue>2</issue>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Alcantara</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Resende</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Paula</surname>
              <given-names>LKGd</given-names>
            </name>
            <name>
              <surname>Silveira</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>MDd</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Harper A. WHOQOL-BREF: Introduction, administration, scoring and generic version of the assessment1996:18. Located at: Programme on mental health. Geneva: WHO; 1996.</mixed-citation>
        <element-citation publication-type="book">
          <source>WHOQOL-BREF: Introduction, administration, scoring and generic version of the assessment1996:18. Located at: Programme on mental health</source>
          <date>
            <year>1996</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Harper</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Mortensen OS, Bjorner JB, Newman B, Oldenburg B, Groenvold M, Madsen JK, et al. Gender differences in health-related quality of life following ST-elevation myocardial infarction: women and men do not benefit from primary percutaneous coronary intervention to the same degree. Eur J Cardiovasc Prev Rehabil. 2007;14(1):37-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Gender differences in health-related quality of life following ST-elevation myocardial infarction: women and men do not benefit from primary percutaneous coronary intervention to the same degree</article-title>
          <source>Eur J Cardiovasc Prev Rehabil</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>37</fpage>
          <lpage>43</lpage>
          <issue>1</issue>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mortensen</surname>
              <given-names>OS</given-names>
            </name>
            <name>
              <surname>Bjorner</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Oldenburg</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Groenvold</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Madsen</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Norekval TM, Wahl AK, Fridlund B, Nordrehaug JE, Wentzel-Larsen T, Hanestad BR. Quality of life in female myocardial infarction survivors: a comparative study with a randomly selected general female population cohort. Health Qual Life Outcomes. 2007;5:58.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quality of life in female myocardial infarction survivors: a comparative study with a randomly selected general female population cohort</article-title>
          <source>Health Qual Life Outcomes</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>58</fpage>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Norekval</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Wahl</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Fridlund</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nordrehaug</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Wentzel-Larsen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hanestad</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39. Hofer S, Kullich W, Graninger U, Brandt D, Gassner A, Klicpera M, et al. Cardiac rehabilitation in Austria: short term quality of life improvements in patients with heart disease. Wien Klin Wochenschr. 2006;118(23-24):744-53.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac rehabilitation in Austria: short term quality of life improvements in patients with heart disease</article-title>
          <source>Wien Klin Wochenschr</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>744</fpage>
          <lpage>53</lpage>
          <issue>23-24</issue>
          <volume>118</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hofer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kullich</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Graninger</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gassner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klicpera</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B40">
        <mixed-citation>40. Rinfret S, Grines CL, Cosgrove RS, Ho KK, Cox DA, Brodie BR, et al. Quality of life after balloon angioplasty or stenting for acute myocardial infarction: one-year results from the Stent-PAMI trial. J Am Coll Cardiol. 2001;38(6):1614-21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quality of life after balloon angioplasty or stenting for acute myocardial infarction: one-year results from the Stent-PAMI trial</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1614</fpage>
          <lpage>21</lpage>
          <issue>6</issue>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rinfret</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Grines</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Cosgrove</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Brodie</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B41">
        <mixed-citation>41. Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998;51(11):903-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>903</fpage>
          <lpage>12</lpage>
          <issue>11</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ware Jr</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Gandek</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B42">
        <mixed-citation>42. Ware JE Jr, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1167-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1167</fpage>
          <lpage>70</lpage>
          <issue>11</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ware Jr</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Gandek</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kosinski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aaronson</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Apolone</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Brazier</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B43">
        <mixed-citation>43. Kristofferzon ML, Lofmark R, Carlsson M. Coping, social support and quality of life over time after myocardial infarction. J Adv Nurs. 2005;52(2):113-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coping, social support and quality of life over time after myocardial infarction</article-title>
          <source>J Adv Nurs</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>113</fpage>
          <lpage>24</lpage>
          <issue>2</issue>
          <volume>52</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kristofferzon</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Lofmark</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Carlsson</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B44">
        <mixed-citation>44. H&#246;fer S, Lim L, Guyatt G, Oldridge N. The MacNew Heart Disease health-related quality of life instrument: a summary. Health Qual Life Outcomes. 2004;2:3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The MacNew Heart Disease health-related quality of life instrument: a summary</article-title>
          <source>Health Qual Life Outcomes</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>3</fpage>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>H&#246;fer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Guyatt</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Oldridge</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B45">
        <mixed-citation>45. Gandek B, Ware JE Jr, Aaronson NK, Alonso J, Apolone G, Bjorner J, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1149-58.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1149</fpage>
          <lpage>58</lpage>
          <issue>11</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gandek</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ware Jr</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Aaronson</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Alonso</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Apolone</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bjorner</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B46">
        <mixed-citation>46. Skevington SM, O'Connell KA. Can we identify the poorest quality of life? Assessing the importance of quality of life using the WHOQOL-100. Qual Life Res. 2004;13(1):23-34.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Can we identify the poorest quality of life: Assessing the importance of quality of life using the WHOQOL-100</article-title>
          <source>Qual Life Res</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>23</fpage>
          <lpage>34</lpage>
          <issue>1</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Skevington</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>O'Connell</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B47">
        <mixed-citation>47. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The Mos 36-item Short-Form Health Survey (Sf-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32(1):40-66.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The Mos 36-item Short-Form Health Survey (Sf-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups</article-title>
          <source>Med Care</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>40</fpage>
          <lpage>66</lpage>
          <issue>1</issue>
          <volume>32</volume>
          <person-group person-group-type="author">
            <name>
              <surname>McHorney</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Ware Jr</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Sherbourne</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B48">
        <mixed-citation>48. Lim LLY, Valenti LA, Knapp JC, Dobson AJ, Plotnikoff R, Higginbotham N, et al. A self-administered quality-of-life questionnaire after acute myocardial-infarction. J Clin Epidemiol. 1993;46(11):1249-56.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A self-administered quality-of-life questionnaire after acute myocardial-infarction</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>1249</fpage>
          <lpage>56</lpage>
          <issue>11</issue>
          <volume>46</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>LLY</given-names>
            </name>
            <name>
              <surname>Valenti</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Knapp</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Dobson</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Plotnikoff</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Higginbotham</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B49">
        <mixed-citation>49. Valenti L, Lim L, Heller RF, Knapp J. An improved questionnaire for assessing quality of life after acute myocardial infarction. Qual Life Res. 1996;5(1):151-61.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>An improved questionnaire for assessing quality of life after acute myocardial infarction</article-title>
          <source>Qual Life Res</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>151</fpage>
          <lpage>61</lpage>
          <issue>1</issue>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Valenti</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Heller</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Knapp</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B50">
        <mixed-citation>50. Fayers PM, Machin D. Scores and measurements: validity, reliability, sensitivity. In: Fayers PM, Machin D, eds. Quality of life: assessment, analysis and interpretation. West Sussex, England: Wiley &amp; Sons; 2001. p. 45-71.</mixed-citation>
        <element-citation publication-type="book">
          <source>Quality of life: assessment, analysis and interpretation</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>45</fpage>
          <lpage>71</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Fayers</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Machin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fayers</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Machin</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B51">
        <mixed-citation>51. Streiner DL, Norman GR. Measuring change. In: Streiner DL, Norman GR, eds. Health measurement scales: a pratical guide to their development and use. 4th ed. New York: Oxford University Press Inc; 2008. p. 277-97.</mixed-citation>
        <element-citation publication-type="book">
          <source>Health measurement scales: a pratical guide to their development and use</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>277</fpage>
          <lpage>97</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Streiner</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Streiner</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B52">
        <mixed-citation>52. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11(3):193-205.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Assessing health status and quality-of-life instruments: attributes and review criteria</article-title>
          <source>Qual Life Res</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>193</fpage>
          <lpage>205</lpage>
          <issue>3</issue>
          <volume>11</volume>
        </element-citation>
      </ref>
      <ref id="B53">
        <mixed-citation>53. Jaeschke R, Singer J, Guyatt GH. Measurement of health-status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407-15.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Measurement of health-status: ascertaining the minimal clinically important difference</article-title>
          <source>Control Clin Trials</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>407</fpage>
          <lpage>15</lpage>
          <issue>4</issue>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jaeschke</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Singer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Guyatt</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B54">
        <mixed-citation>54. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation</article-title>
          <source>Med Care</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>582</fpage>
          <lpage>92</lpage>
          <issue>5</issue>
          <volume>41</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Norman</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Sloan</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Wyrwich</surname>
              <given-names>KW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B55">
        <mixed-citation>55. Dixon T, Lim LL, Oldridge NB. The MacNew heart disease health-related quality of life instrument: reference data for users. Qual Life Res. 2002;11(2):173-83.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The MacNew heart disease health-related quality of life instrument: reference data for users</article-title>
          <source>Qual Life Res</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>173</fpage>
          <lpage>83</lpage>
          <issue>2</issue>
          <volume>11</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dixon</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Oldridge</surname>
              <given-names>NB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B56">
        <mixed-citation>56. Arnold SV, Spertus JA, Jones PG, Xiao L, Cohen DJ. The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry. Am Heart J. 2009;157(6):1041-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>1041</fpage>
          <lpage>9</lpage>
          <issue>6</issue>
          <volume>157</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Arnold</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Spertus</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B57">
        <mixed-citation>57. Ware JE, Snow KK, Kosinski M, Gandek B. Validity: content and criterion-based interpretation. In: Ware JE, ed. SF-36 Health survey - manual &amp; interpretation guide. Lincoln, RI: QualityMetric Incorporated; 1993. p. 2002:9.1-9.34.</mixed-citation>
        <element-citation publication-type="book">
          <source>SF-36 Health survey - manual &amp; interpretation guide</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>2002</fpage>
          <person-group person-group-type="author">
            <name>
              <surname>Ware</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Snow</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Kosinski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gandek</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ware</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B58">
        <mixed-citation>58. Simpson E, Pilote L. Quality of life after acute myocardial infarction: a systematic review. Can J Cardiol. 2003;19(5):507-11.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quality of life after acute myocardial infarction: a systematic review</article-title>
          <source>Can J Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>507</fpage>
          <lpage>11</lpage>
          <issue>5</issue>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Simpson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pilote</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B59">
        <mixed-citation>59. Coelho R, Prata J. Quality of life measures in acute coronary syndromes: the evaluation of predictors in this field of research. In: Preedy VR, Watson RR, eds. Handbook of disease burdens and quality of life measures. New York: Springer; 2010. p. 3015-33.</mixed-citation>
        <element-citation publication-type="book">
          <source>Handbook of disease burdens and quality of life measures</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>3015</fpage>
          <lpage>33</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Coelho</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Prata</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Preedy</surname>
              <given-names>VR</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B60">
        <mixed-citation>60. Ciconelli RM, Ferraz MB, Santos W, Meinao I, Quaresma MR. Brazilian-Portuguese version of the SF-36 questionnaire: a reliable and valid quality of life outcome measure. Arthritis Rheum. 1997;40(9):489.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Brazilian-Portuguese version of the SF-36 questionnaire: a reliable and valid quality of life outcome measure</article-title>
          <source>Arthritis Rheum</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>489</fpage>
          <issue>9</issue>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ciconelli</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Ferraz</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Meinao</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Quaresma</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B61">
        <mixed-citation>61. Fleck MPA, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, et al. [Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref]. Rev Saude Publica. 2000;34(2):178-83.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref</article-title>
          <source>Rev Saude Publica</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>178</fpage>
          <lpage>83</lpage>
          <issue>2</issue>
          <volume>34</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fleck</surname>
              <given-names>MPA</given-names>
            </name>
            <name>
              <surname>Louzada</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Xavier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chachamovich</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vieira</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B62">
        <mixed-citation>62. Franzen E. Avalia&#231;&#227;o da qualidade de vida em cardiopatia isqu&#234;mica: valida&#231;&#227;o de instrumentos para uma popula&#231;&#227;o brasileira. [Tese]. Porto Alegre: Faculdade de Medicina, Universidade Federal do Rio Grande do Sul; 2005.</mixed-citation>
        <element-citation publication-type="book">
          <source>Avalia&#231;&#227;o da qualidade de vida em cardiopatia isqu&#234;mica: valida&#231;&#227;o de instrumentos para uma popula&#231;&#227;o brasileira</source>
          <person-group person-group-type="author">
            <name>
              <surname>Franzen</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Evaluaci&#243;n de la calidad de vida despu&#233;s del s&#237;ndrome coronario agudo: revisi&#243;n sistem&#225;tica</article-title>
      </title-group>
      <kwd-group xml:lang="es">
        <kwd>S&#237;ndrome coronario agudo</kwd>
        <kwd>calidad de vida</kwd>
        <kwd>perfil de impacto de la enfermedad</kwd>
        <kwd>revisi&#243;n</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO DE REVISI&#211;N</bold>
      </p>
      <p>
        <fn id="enda-body2">
          <label>
            <bold>Evaluaci&#243;n de la calidad de vida despu&#233;s del s&#237;ndrome coronario agudo: revisi&#243;n sistem&#225;tica</bold>
          </label>
          <p>
            <bold>Suzana Alves da Silva<sup>I,II,III</sup>; Sonia Regina Lambert Passos<sup>IV</sup>; Mariana Teixeira Carballo<sup>III</sup>; Mabel Figueir&#243;<sup>III</sup>; Investigadores<sup>II,V</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Escola Nacional de Sa&#250;de P&#250;blica - ENSP - Fiocruz</p>
      <p> IPROCEP Centro de Ensino e Pesquisa</p>
      <p><sup>III</sup>Hospital do Cora&#231;&#227;o - IEP - Hcor</p>
      <p><sup>IV</sup>Instituto de Pesquisa Cl&#237;nica Evandro Chagas - IPEC - Fiocruz</p>
      <p><sup>V</sup>Secretaria Municipal de Sa&#250;de e Defesa Civil - SMSDC-RJ, Rio de Janeiro - RJ, Brasil</p>
      <p>Correspondencia</p>
      <p><bold>Palabras clave:</bold> S&#237;ndrome coronario agudo, calidad de vida, perfil de impacto de la enfermedad, revisi&#243;n.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>El Infarto Agudo del Miocardio (IAM), es mundialmente conocido desde los primordios del siglo XX, como una enfermedad casi siempre fatal. El impacto f&#237;sico y psicoemocional provocado por la enfermedad, y la elevada prevalencia de la depresi&#243;n, han sido indicados como los principales factores que contribuyen para el da&#241;o a la calidad de vida (CV) de esos pacientes a medio y largo plazo<sup>1-3</sup>.</p>
      <p>Una revisi&#243;n sistem&#225;tica de los estudios que evaluaron la CV posterior al infarto agudo del Miocardio, demostr&#243; que los efectos del infarto sobre la CV se disipan a largo plazo, pero la evaluaci&#243;n espec&#237;fica de los pacientes que evolucionan con un compromiso de la funci&#243;n ventricular izquierda, en la fase aguda del evento, no parece haber sido realizada<sup>4</sup>. Adem&#225;s de eso, dos estudios indican que las consecuencias tanto de la enfermedad coronaria isqu&#233;mica cr&#243;nica, como de la insuficiencia card&#237;aca no son temporales, y que sus efectos en la mensuraci&#243;n de la CV empeoran justamente despu&#233;s del diagn&#243;stico, sin presentar una mejor&#237;a en el seguimiento de los pacientes, a diferencia de lo que ha sido relatado despu&#233;s de un evento agudo<sup>4,5</sup>.</p>
      <p>Aunque los sistemas de salud siempre refuercen el control de la morbilidad y de la mortalidad, las preocupaciones m&#225;s recientes tambi&#233;n han estimulado la evaluaci&#243;n del impacto provocado por los agravamientos de la salud en la vida diaria de los pacientes. A menudo, esas cuantificaciones se hacen por medio de cuestionarios desarrollados y validados a trav&#233;s de una metodolog&#237;a espec&#237;fica, que involucra su replicaci&#243;n en otras poblaciones que no son la poblaci&#243;n original en que se desarrollaron originalmente. </p>
      <p>Son numerosos los instrumentos para evaluar la CV en pacientes con cardiopat&#237;a isqu&#233;mica y metodolog&#237;as espec&#237;ficas han sido desarrolladas para la traducci&#243;n, adaptaci&#243;n cultural e interpretaci&#243;n de los instrumentos cuando han sido aplicados a otros idiomas. Esta revisi&#243;n sistem&#225;tica desea analizar los instrumentos traducidos al portugu&#233;s que fueron utilizados para evaluar la calidad de vida en pacientes con el s&#237;ndrome coronario agudo (SCA), y la interpretaci&#243;n de sus resultados de acuerdo con sus propiedades psicom&#233;tricas.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>
        <bold>Estrategia de b&#250;squeda</bold>
      </p>
      <p>La investigaci&#243;n bibliogr&#225;fica fue realizada por una bibliotecaria especializada en el &#225;rea de ciencias m&#233;dicas y experta en software de gerenciamiento de referencias (Endnote versi&#243;n 13.0). La b&#250;squeda no se restringi&#243; al idioma o a los per&#237;odos. Los portales, respectivas bases y sintaxis utilizadas aparecen en la <xref ref-type="table" rid="es_a13tab01m-body2">Tabla 1</xref>. Fue realizada una b&#250;squeda manual de referencias cruzadas relevantes. </p>
      <p content-type="asset">
        <table-wrap id="es_a13tab01m-body2">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt01-es.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Criterios de selecci&#243;n de las referencias y extracci&#243;n de los datos</bold>
      </p>
      <p>La selecci&#243;n de las referencias y la recolecci&#243;n de informaciones fueron realizadas secundando el <italic>guideline</italic> Prisma<sup>6</sup>, por medio de dos investigadores entrenados e independientes. La selecci&#243;n de las referencias fue hecha a trav&#233;s de la lectura de los res&#250;menes oriundos de la investigaci&#243;n bibliogr&#225;fica (<xref ref-type="table" rid="es_a13tab01m-body2">tabla 1</xref>), y de la extracci&#243;n de los datos realizada a trav&#233;s de la lectura del texto completo de las referencias seleccionadas para las variables de inter&#233;s.</p>
      <p>Fueron incluidos en el an&#225;lisis todos los estudios que evaluaron la calidad de vida de pacientes con diagn&#243;stico de s&#237;ndrome coronario agudo o infarto agudo del miocardio, utilizando instrumentos traducidos para el idioma portugu&#233;s. </p>
      <p>Los estudios fueron incluidos en el an&#225;lisis independientemente del perfil y de la extensi&#243;n del seguimiento. Los estudios con resultados fuera de los l&#237;mites de variaci&#243;n de las escalas fueron excluidos.</p>
      <p>Variables seleccionadas y desenlaces de inter&#233;s</p>
      <p>Fueron analizados los desenlaces de calidad de vida definidos como las puntuaciones totales y resumidas de cada instrumento, seg&#250;n el tiempo transcurrido entre el diagn&#243;stico del s&#237;ndrome coronario agudo y la aplicaci&#243;n del instrumento y de acuerdo con las caracter&#237;sticas cl&#237;nicas y el perfil sociodemogr&#225;fico de la poblaci&#243;n incluida en el an&#225;lisis. Los resultados de validez, que comprenden la validez de criterio (sensibilidad, especificidad, raz&#243;n de verosimilitud), y de concepto (coeficiente de correlaci&#243;n de Pearson); confiabilidad, comprendiendo la consistencia interna (Test a-Cronbach) y reproductibilidad (Coeficiente de Correlaci&#243;n Intra-Clase o Kappa ponderado), como tambi&#233;n la sensibilidad, el nivel de respuesta e interpretaci&#243;n, fueron investigados, y solamente se describieron los resultados que fueron encontrados.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Las referencias seleccionadas, como tambi&#233;n los datos recolectados fueron registrados en la base de datos ACCESS versi&#243;n 2007, construida espec&#237;ficamente con ese objetivo.</p>
      <p>Las variables cuantitativas fueron resumidas por promedios y desviaciones est&#225;ndar como m&#233;trica de las puntuaciones de calidad de vida y de las propiedades psicom&#233;tricas de los instrumentos evaluados. La heterogeneidad entre los estudios fue evaluada con base en el Test Cochrane Q<sup>2</sup> con un nivel de significancia de un 10%<sup>7</sup>. El Test I<sup>2</sup> tambi&#233;n fue utilizado para cuantificar la heterogeneidad entre los estudios en una escala de 0 a 100%. Los estudios con I<sup>2</sup>&gt; 75% fueron considerados altamente heterog&#233;neos. La combinaci&#243;n de los resultados se hizo utilizando los promedios y las desviaciones est&#225;ndar de los estudios considerando el promedio ponderado por el tama&#241;o de la muestra y de acuerdo con la metodolog&#237;a estandarizada por la Cochrane<sup>8</sup>. Los datos de los estudios longitudinales fueron consolidados por un modelo de efectos aleatorios que consider&#243; el Inverso de la Variancia como medida de ponderaci&#243;n para comparar los resultados antes y despu&#233;s, con relaci&#243;n al momento de la aplicaci&#243;n de los cuestionarios. Este momento fue definido respecto del diagn&#243;stico de la SCA y estratificado en: <underline>&lt;</underline> 2 meses y &gt; 2 meses, y comparados entre s&#237;. Para los estudios seccionales, la comparaci&#243;n entre los dos momentos se hizo considerando los datos imputados del promedio ponderado de los dem&#225;s estudios en aquel per&#237;odo (antes o despu&#233;s).</p>
      <p>Los test estad&#237;sticos fueron realizados en el programa RevMan 5 (Cochrane), considerando un nivel de significancia de un 5%. Todos los test fueron bicaudales.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Selecci&#243;n de las referencias y de las caracter&#237;sticas de los estudios incluidos</p>
      <p>Los resultados de la estrategia de b&#250;squeda y selecci&#243;n de referencias est&#225;n descritos en la <xref ref-type="fig" rid="es_a13fig01m-body2">figura 1</xref> y las caracter&#237;sticas de los estudios seleccionados en la <xref ref-type="table" rid="es_a13tab01m-body2">tabla 1</xref>. Fueron localizadas 4 revisiones<sup>9-12</sup> que sirvieron de base para la b&#250;squeda de referencias cruzadas.</p>
      <p content-type="asset">
        <fig id="es_a13fig01m-body2">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gf01-es.jpg"/></fig>
      </p>
      <p>De los 2990 res&#250;menes revisados, 18 textos completos fueron incluidos en la s&#237;ntesis cualitativa de los cuales: 3 Cohortes<sup>13-15</sup>, 2 casos-controles<sup>16,17</sup>, 11 seccionales<sup>18-28</sup>, 1 ensayo cl&#237;nico no randomizado<sup>29</sup> y 1 ensayo cl&#237;nico randomizado<sup>30</sup>. Fueron excluidos 3 res&#250;menes cuyos textos completos no fueron publicados<sup>31-33</sup> y dos publicaciones con datos de los mismos pacientes de otros dos estudios incluidos en el an&#225;lisis<sup>34,35</sup>. Un n&#250;mero expresivo de p&#233;rdidas se observ&#243; en 7 de los 18 estudios incluidos. Tres estudios usaron instrumentos diferentes que no pudieron ser incluidos en la s&#237;ntesis cuantitativa, 1 sobre el Seattle<sup>15</sup>, 1 sobre IPQ (del ingl&#233;s, <italic>Illness Perception Questionnaire</italic>)<sup>28</sup> y 1 sobre NHP (del ingl&#233;s, <italic>Nothinghan Health Profile</italic>)<sup>16</sup>. Cuatro estudios aportaron para el metan&#225;lisis (<xref ref-type="fig" rid="es_a13fig01m-body2">figura 1</xref>).</p>
      <p>La Calidad de vida pos-SCA se evalu&#243; en las poblaciones seleccionadas del sur y del sudeste de Brasil, como tambi&#233;n de los distritos de Porto y de Coimbra en Portugal, en su gran mayor&#237;a eran pacientes atendidos en ambulatorios de cardiolog&#237;a o programas de rehabilitaci&#243;n de hospitales universitarios (<xref ref-type="table" rid="es_a13tab02m-body2">tabla 2</xref>).</p>
      <p content-type="asset">
        <table-wrap id="es_a13tab02m-body2">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt02-es.jpg"/></table-wrap>
      </p>
      <p>La selecci&#243;n de pacientes en esos estudios fue hecha a trav&#233;s de la b&#250;squeda en los registros de las historias cl&#237;nicas de los pacientes, o en el registro del hospital y el tama&#241;o de la muestra fue definido por conveniencia. El tiempo transcurrido desde el diagn&#243;stico de la SCA y la aplicaci&#243;n del cuestionario vari&#243; entre los estudios y no est&#225; claro en 2 de ellos. En 7 estudios el tiempo fue inferior a 2 meses y en 9 vari&#243; de 2 meses a 12 a&#241;os. El m&#233;todo de aplicaci&#243;n del cuestionario, por entrevista, por contacto telef&#243;nico o autoaplicaci&#243;n, fue descrito en solamente 6 estudios, no quedando claro en 2 estudios y no siendo relatado en los dem&#225;s (<xref ref-type="table" rid="es_a13tab02m-body2">tabla 2</xref>).</p>
      <p>La mayor&#237;a de los estudios no informa sobre la historia previa, los h&#225;bitos, con excepci&#243;n del tabaquismo, y las caracter&#237;sticas sociodemogr&#225;ficas de las poblaciones estudiadas (<xref ref-type="table" rid="es_a13tab03m-body2">tabla 3</xref>). Ninguno de los estudios seleccionados ajust&#243; sus resultados para cualquier una de esas caracter&#237;sticas. Los ingresos familiares fueron inferiores a 4 salarios m&#237;nimos<sup>19,25,26,28</sup> y la escolaridad inferior a 4 a&#241;os en m&#225;s del 50% de la poblaci&#243;n estudiada, con excepci&#243;n del estudio de Dias et al<sup>13</sup>, que excluy&#243; a los pacientes con una baja escolaridad. Solamente dos estudios describieron el porcentaje de pacientes que retornaron al trabajo despu&#233;s del evento coronario, variando de un 26%<sup>19</sup> a un 52%<sup>28</sup>.</p>
      <p content-type="asset">
        <table-wrap id="es_a13tab03m-body2">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt03-es.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Cuestionarios de Calidad de Vida</bold>
      </p>
      <p>Los cuestionarios de Calidad de vida que m&#225;s se usaron fueron: SF-36, en nueve estudios; MacNew, en seis estudios; WHOQOL, en tres de ellos y Seattle, IPQ y NHP en un estudio cada uno. Las puntuaciones resumidas y globales que se obtuvieron en los per&#237;odos antes y despu&#233;s de 2 meses, como tambi&#233;n el promedio de la diferencia en los dos momentos, est&#225;n en los cuestionarios SF-36 y MacNew en las <xref ref-type="fig" rid="es_a13fig02m-body2">figuras 2</xref> y <xref ref-type="fig" rid="es_a13fig03m-body2">3</xref>, respectivamente, tanto para los estudios seccionales como para los longitudinales. Los dos metan&#225;lisis realizados para los estudios longitudinales indican una mejor&#237;a de la calidad de vida en el seguimiento tard&#237;o, de 0,55 (IC95% 0,34-0,76) para el cuestionario de MacNew y de 5,87 (IC95% 3,42-8,31) para el SF-36, en comparaci&#243;n con el seguimiento inicial, que fue de 2 meses posteriores al diagn&#243;stico de la SCA. Los dos metan&#225;lisis realizados para los estudios longitudinales, demostraron una mejor&#237;a de la calidad de vida en el seguimiento tard&#237;o, de 0,55(IC95% 0,34-0,76) para el cuestionario de MacNew y de 5,87(IC95% 3,42-8,31) para el SF-36, en comparaci&#243;n con el seguimiento inicial, que fue de 2 meses despu&#233;s del diagn&#243;stico de la SCA. </p>
      <p content-type="asset">
        <fig id="es_a13fig02m-body2">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gf02-es.jpg"/></fig>
      </p>
      <p content-type="asset">
        <fig id="es_a13fig03m-body2">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gf03-es.jpg"/></fig>
      </p>
      <p>Los promedios ponderados del SF36, MacNew y WHOQOL<sup>36</sup> como tambi&#233;n los resultados del Seattle observados en el estudio de Souza et al<sup>15</sup>, fueron similares a los observados en pacientes con el s&#237;ndrome coronario agudo en otros pa&#237;ses (<xref ref-type="table" rid="es_a13tab04m-body2">tabla 4</xref>)<sup>37-40</sup>, e inferiores a las puntuaciones observadas en la poblaci&#243;n general de los Estados Unidos y de otros pa&#237;ses (<xref ref-type="table" rid="es_a13tab04m-body2">tabla 4</xref>)<sup>41</sup>, con excepci&#243;n de las medidas resumidas que tuvieron un comportamiento m&#225;s parecido con el de la poblaci&#243;n general de otros pa&#237;ses que con el de la poblaci&#243;n con SCA<sup>42</sup>.</p>
      <p content-type="asset">
        <table-wrap id="es_a13tab04m-body2">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt04-es.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Propriedades Psicom&#233;tricas</bold>
      </p>
      <p>Las propiedades psicom&#233;tricas de los cuestionarios MacNew, WHOQOL y SF36 fueron evaluadas en 4 de los 18 estudios analizados. <underline>Validez de concepto del tipo convergente</underline> que fue analizada a trav&#233;s de la correlaci&#243;n de Pearson entre los cuestionarios MacNew, enfermedad-espec&#237;fico, y SF-36, general (Alc&#226;ntara<sup>25</sup>, Leal et al<sup>14</sup> y Nakajima et al<sup>19</sup>), y entre los cuestionarios WHOQOL-breve y SF-36, ambos generales (Cruz et al<sup>26</sup>).</p>
      <p>Las puntuaciones de salud mental, vitalidad y capacidad funcional (MacNew), presentaron los valores de correlaci&#243;n &gt; 0,60 con todas las puntuaciones del SF-36, mientras que la puntuaci&#243;n emocional qued&#243; con solo dos dominios: salud mental (r = 0,78) y vitalidad (r = 0,69)<sup>19,25</sup>. Las correlaciones entre las puntuaciones del MacNew y del SF-36 fueron &gt; 0,6 para las puntuaciones salud mental, vitalidad y capacidad funcional<sup>19</sup>. Las correlaciones entre el componente f&#237;sico del SF-36 y las puntuaciones global y f&#237;sica del MacNew fueron de 0,70 y 0,72, respectivamente, y entre el componente mental del SF-36 y la puntuaci&#243;n emocional del MacNew fue de 0,78 (Leal et al<sup>14</sup>). La correlaci&#243;n entre las puntuaciones emocionales de los dos cuestionarios vari&#243; de -0,15 (Alc&#226;ntara et al<sup>25</sup>) a 0,45 (Nakajima et al<sup>19</sup>), y entre las puntuaciones sociales vari&#243; de 0,49 a 0,58 entre los estudios<sup>14,19,25</sup>. Leal et al<sup>14</sup> observaron correlaciones significativas (r &gt; 0,70) entre las puntuaciones globales y resumidas de ambos cuestionarios dentro de las mismas dimensiones (componente f&#237;sico del SF-36 vs. puntuaci&#243;n global y puntuaci&#243;n f&#237;sica del MacNew y componente mental del SF-36 vs. puntuaci&#243;n emocional del MacNew). Cruz et al<sup>26</sup> encontraron una correlaci&#243;n de Pearson significativa (r &gt; 0,55) entre la puntuaci&#243;n f&#237;sica del WHOQOL y todas las puntuaciones del SF-36 (excepto para las puntuaciones limitaci&#243;n f&#237;sica y estado emocional), y entre la puntuaci&#243;n psicol&#243;gica del WHOQOL y las puntuaciones de salud mental y vitalidad del SF-36. Las puntuaciones vitalidad (r = 0,58) y salud mental del SF-36 (r = 0,68), y todos las puntuaciones del cuestionario WHOQOL (r &gt; 0,55), se correlacionaron moderadamente con el cuestionario de depresi&#243;n de Beck<sup>26</sup>.</p>
      <p><underline>La validez de concepto del tipo desglose</underline> fue investigada en los estudios de Nakajima et al<sup>19</sup> y Leal et al<sup>14</sup>. Los pacientes con disfunci&#243;n ventricular grave presentaron puntuaciones de calidad de vida significativamente m&#225;s bajas comparadas con los que ten&#237;an disfunci&#243;n ventricular leve o moderada<sup>19</sup>. El cuestionario de MacNew fue capaz de desglosar significativamente los pacientes con disfunci&#243;n grave del ventr&#237;culo izquierdo de los dem&#225;s, como tambi&#233;n pacientes con un empeoramiento evolutivo en las puntuaciones del cuestionario SF-36 de aquellos con una mejor&#237;a o sin cambios es esas puntuaciones. El cuestionario de MacNew tambi&#233;n pudo desglosar a los pacientes con y sin depresi&#243;n o ansiedad, por medio de la escala hospitalaria de ansiedad y depresi&#243;n<sup>14</sup>.</p>
      <p>La <underline>consistencia interna</underline> (&#945;-Cronbach) del SF-36 y del WHOQOL, evaluada por Cruz et al<sup>26</sup>, fue &gt; 0,7 para todas las dimensiones excepto para la puntuaci&#243;n social. En los estudios de Nakajima et al<sup>19</sup> y Leal et al<sup>14</sup>, que evaluaron el cuestionario de MacNew, la consistencia interna fue &gt;0,8 para todas las dimensiones. Esos resultados se parecen con lo que fue observado en otros pa&#237;ses (<xref ref-type="table" rid="es_a13tab05m-body2">tabla 5</xref>)<sup>43-46</sup>.</p>
      <p content-type="asset">
        <table-wrap id="es_a13tab05m-body2">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt05-es.jpg"/></table-wrap>
      </p>
      <p>La <underline>reproductibilidad</underline> se evalu&#243; exclusivamente por Leal et al<sup>14</sup> a trav&#233;s de la correlaci&#243;n intra-clase y del doble test para el cuestionario de MacNew, con resultados variando de 0,77 a 0,93, tambi&#233;n con resultados parecidos a los de los otros pa&#237;ses (<xref ref-type="table" rid="es_a13tab05m-body2">tabla 5</xref>)<sup>44</sup>.</p>
      <p>El <underline>efecto piso-l&#237;mite</underline>, presente cuando se superaba el 10%<sup>47</sup>, fue observado en las puntuaciones "estado emocional" y "limitaci&#243;n f&#237;sica" del SF-36 evaluado en el estudio de Cruz et al<sup>26</sup>. Ese efecto no estuvo presente en el cuestionario de MacNew evaluado en el estudio de Leal et al<sup>14</sup>.</p>
      <p>
        <bold>Heterogeneidad</bold>
      </p>
      <p>estudios longitudinales incluidos en los metan&#225;lisis presentaron una heterogeneidad moderada. La meta-regresi&#243;n para la evaluaci&#243;n de las causas de la heterogeneidad, no se hizo en funci&#243;n de la ausencia e inconsistencia de las informaciones en la mayor&#237;a de los estudios. Las posibles causas de heterogeneidad pueden estar relacionadas con los diferentes proyectos de estudios incluidos en el an&#225;lisis y con los m&#233;todos utilizados para la selecci&#243;n de los sujetos de investigaci&#243;n y aplicaci&#243;n del cuestionario. Otra posible fuente de heterogeneidad fue el tiempo transcurrido entre el s&#237;ndrome coronario agudo y el momento de la aplicaci&#243;n del cuestionario, principalmente en el grupo clasificado como evaluaci&#243;n "&gt; 2 meses", que vari&#243; de 3 meses a 6 a&#241;os desde el diagn&#243;stico. Adem&#225;s de eso, algunos datos necesitaron ser imputados con base en el promedio ponderado de los restantes estudios dentro de la misma categor&#237;a, de forma que la comparaci&#243;n de los promedios antes y despu&#233;s, pudiese ser realizada para los estudios encontrados. Las caracter&#237;sticas cl&#237;nicas y sociodemogr&#225;ficas, cuando se relatan, tambi&#233;n variaron bastante entre los estudios y parecen homog&#233;neas apenas para la franja etaria y el sexo (<xref ref-type="table" rid="es_a13tab03m-body2">tabla 3</xref>).</p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>Esta revisi&#243;n sistem&#225;tica ha realizado una investigaci&#243;n sobre lo que ha sido hecho en Brasil y en Portugal con relaci&#243;n al tema "calidad de vida", en la coronariopat&#237;a aguda, teniendo en cuenta los resultados de las puntuaciones de calidad de vida por diferentes instrumentos, y de acuerdo con el tiempo de enfermedad y con sus propiedades psicom&#233;tricas. </p>
      <p>Las propiedades psicom&#233;tricas de los instrumentos fueron evaluadas en solo 4 de los 18 estudios analizados, 3 de los cuales evaluaron la asociaci&#243;n de un cuestionario general (SF-36), a un cuestionario espec&#237;fico (MacNew), que a continuaci&#243;n discutimos.</p>
      <p>
        <bold>Validez de concepto</bold>
      </p>
      <p>La validez de concepto, fue evaluada de acuerdo con los m&#233;todos previamente establecidos<sup>48,49</sup> y demostr&#243; lo siguiente: 1) una elevada convergencia entre los &#237;tems del cuestionario MacNew y SF-36, considerando el mismo concepto, con excepci&#243;n de las puntuaciones emocionales, probablemente porque esas miden diferentes aspectos de la calidad de vida. Mientras que el MacNew se preocupa con la percepci&#243;n del paciente, el SF-36 se preocupa con el impacto del estado emocional en sus actividades diarias; 2) una elevada convergencia se observ&#243; entre todas las dimensiones del WHOQOL-breve y apenas la puntuaci&#243;n de salud mental del SF-36, pero no entre las dem&#225;s puntuaciones de este instrumento, probablemente un reflejo del hecho de que los dos cuestionarios presentan objetivos bien diferentes. Mientras el SF-36 fue elaborado para evaluar los estados de salud, el WHOQOL fue elaborado para evaluar la percepci&#243;n del paciente con relaci&#243;n a los diferentes aspectos de su vida, de una forma global; 3) baja capacidad de desglose de los cuestionarios generales, en contraposici&#243;n con la buena capacidad de desglose del cuestionario espec&#237;fico MacNew para cambios en la calidad de vida, relacionados con los s&#237;ntomas de insuficiencia card&#237;aca o depresi&#243;n y 4) moderada capacidad de desglose del cuestionario WHOQOL en presencia de la depresi&#243;n. </p>
      <p>Los an&#225;lisis de validez de concepto del tipo desglose estuvieron restringidos al cuestionario de MacNew, el cual mostr&#243; una buena capacidad de desglose entre los pacientes con y sin disfunci&#243;n ventricular grave, depresi&#243;n y ansiedad, comparado con las observaciones longitudinales con el SF-36. Las clases funcionales de angina o insuficiencia card&#237;aca no fueron evaluadas, pero los estudios previos sugieren que esos cuestionarios poseen una baja propiedad de desglose para esos &#237;tems<sup>3</sup>.</p>
      <p>La validez de criterio no se evalu&#243; en ninguno de los estudios incluidos en esta revisi&#243;n y su importancia se relacionar&#237;a con la determinaci&#243;n de la exactitud, principalmente de los instrumentos espec&#237;ficos para la definici&#243;n de la presencia o de la ausencia de condiciones cl&#237;nicas de inter&#233;s, tales como reobstrucci&#243;n coronaria o insuficiencia card&#237;aca durante el seguimiento cl&#237;nico de esos pacientes. </p>
      <p>
        <bold>Confiabilidad</bold>
      </p>
      <p>La consistencia interna evaluada por el alfa de Cronbach fue baja para la puntuaci&#243;n social de los cuestionarios generales tanto del SF-36 como el WHOQOL, mientras que los cuestionarios espec&#237;ficos MacNew y Seattle, se comportaron de forma diferente de los cuestionarios generales y presentaron una consistencia interna elevada en todas sus dimensiones.</p>
      <p>La reproductibilidad, considerada satisfactoria cuando queda por encima del 0,50 para la comparaci&#243;n entre los grupos, y por encima 0,90 para la evaluaci&#243;n del individuo con &#233;l mismo<sup>44,47</sup>, se evalu&#243; solamente para el cuestionario MacNew en 1 de los estudios, demostrando que este cuestionario present&#243; una elevada confiabilidad en la poblaci&#243;n estudiada<sup>14</sup>.</p>
      <p>
        <bold>Sensibilidad</bold>
      </p>
      <p>Las dimensiones del SF-36 que contemplan el estado emocional y la funci&#243;n social mostraron un efecto piso-l&#237;mite elevado, lo que tambi&#233;n qued&#243; evidente, de forma moderada, en las dimensiones de dolor corporal y limitaci&#243;n f&#237;sica, compatible con lo observado en estudios previos<sup>45,46</sup>. La propensi&#243;n al efecto piso-l&#237;mite fue baja para los cuestionarios espec&#237;ficos de MacNew y de Seattle. Aunque el efecto piso-l&#237;mite haya sido descrito como un buen par&#225;metro para inferir en la sensibilidad de los instrumentos de la calidad de vida, una vez que indica si el instrumento es capaz de detectar las variaciones entre los individuos que no sean los extremos de la medida, es visto como un m&#233;todo considerado por muchos autores como insuficiente para evaluar si el instrumento puede detectar peque&#241;as diferencias<sup>50</sup>. El m&#233;todo que ha sido propuesto para la evaluaci&#243;n de esta propiedad es el de la magnitud de efecto entre los grupos, por medio de test estad&#237;sticos espec&#237;ficos, tales como el tama&#241;o del efecto de Cohen, el indicador de respuesta de Guyatt, y el promedio est&#225;ndar de la diferencia, lo que no se hizo en ninguno de los estudios analizados<sup>50,51</sup>.</p>
      <p>
        <bold>Capacidad de Respuesta </bold>
      </p>
      <p>La interpretaci&#243;n en el cambio de las puntuaciones de calidad de vida con el tiempo es otra cuesti&#243;n de alta relevancia en el seguimiento de pacientes con cardiopat&#237;a isqu&#233;mica<sup>52</sup>. El efecto piso-l&#237;mite, tambi&#233;n ha sido utilizado como un indicador &#250;til de capacidad de respuesta del instrumento<sup>50</sup>, pero el concepto m&#225;s ampliamente utilizado en la literatura es el de la "Diferencia M&#237;nima que Importa", (MID, del ingl&#233;s "<italic>minimal important difference</italic>"), y que representa la menor diferencia en la puntuaci&#243;n del dominio de inter&#233;s que es percibida por el paciente y que determinar&#237;a, en la ausencia de limitaciones cl&#237;nicas o financieras, un cambio en la conducta terap&#233;utica del paciente<sup>53,54</sup>. Norman et al<sup>54</sup>, bas&#225;ndose en una revisi&#243;n sistem&#225;tica de estudios de calidad de vida, demostraron que la MID puede ser estimada con base en la &#189; de la desviaci&#243;n est&#225;ndar del promedio de las puntuaciones resultantes de la aplicaci&#243;n inicial del instrumento en esa poblaci&#243;n<sup>54</sup>. Ya ha sido demostrado que un cambio de como m&#237;nimo 0,5 y 3,5 son indicadores &#250;tiles para MID en las puntuaciones de los cuestionarios MacNew y Seattle, respectivamente<sup>55,56</sup>. Para el cuestionario SF-36 una variaci&#243;n en torno de 10 puntos para las puntuaciones individuales, represent&#243; un cambio acentuado en la percepci&#243;n de la salud de los pacientes, mientras que un cambio en torno de 5 puntos represent&#243; un cambio moderado<sup>57</sup>. En esta revisi&#243;n, solamente 4 de los 18 estudios encontrados permitieron ese an&#225;lisis, con valores encontrados de 0,55 puntos para el MacNew y de 5,78 puntos para el SF-36, consistentes con lo que ha sido establecido como MID para esos instrumentos. Un cambio de aproximadamente 15 puntos se observ&#243; en el &#250;nico estudio que evalu&#243; el cuestionario de Seattle<sup>15</sup>. Esa gran variaci&#243;n puede estar relacionada con el momento de la primera aplicaci&#243;n del instrumento, que se hizo cuando el paciente accedi&#243; al hospital, y estaba con fuertes s&#237;ntomas<sup>15</sup>. Con excepci&#243;n del cuestionario de Seattle, tales hallazgos corroboran los resultados de la revisi&#243;n sistem&#225;tica de Simpson, que indica que ocurre una recuperaci&#243;n modesta de la calidad de vida despu&#233;s de un evento coronario agudo<sup>58</sup>.</p>
      <p>Los resultados de una revisi&#243;n sistem&#225;tica previa, producida por Dempster et al<sup>59</sup>, sugieren que los cuestionarios generales tales como el SF-36 y el <italic>Nothinghan Health Profile</italic>, poseen una baja capacidad de respuesta y por lo tanto, sus resultados deben ser interpretados con cautela, una vez que esos instrumentos son poco sensibles para capturar peque&#241;as variaciones evolutivas en la calidad de vida de los pacientes con cardiopat&#237;a isqu&#233;mica. Adem&#225;s de Dempster, otros autores han sugerido que un cuestionario espec&#237;fico deba estar siempre asociado a un cuestionario general para la evaluaci&#243;n de la calidad de vida de pacientes con cardiopat&#237;a isqu&#233;mica<sup>3,59</sup>.</p>
      <p>
        <bold>Validaci&#243;n transcultural</bold>
      </p>
      <p>Aunque los instrumentos generales como el WHOQOL y el SF-36, que fueron los m&#225;s extensamente utilizados en los estudios evaluados, en la gran mayor&#237;a de forma aislada, fueron validados en portugu&#233;s y en pacientes con caracter&#237;sticas cl&#237;nicas completamente diferentes de las presentadas por los pacientes portadores de enfermedad coronaria<sup>60,61</sup>, las evaluaciones previas indican que por lo menos el SF-36 presenta una elevada confiabilidad en diferentes culturas y en diferentes condiciones cl&#237;nicas, y en Brasil, present&#243; una reproductibilidad adecuada en una poblaci&#243;n de pacientes con angina estable<sup>62</sup>. Los dem&#225;s instrumentos (Seattle, MacNew y NHP), enfermedad-espec&#237;ficos, fueron validados en la poblaci&#243;n de inter&#233;s. Aunque exista un registro de traducci&#243;n y de validaci&#243;n del cuestionario de Seattle para pacientes brasile&#241;os con angina estable, los detalles del proceso de traducci&#243;n transcultural no se han descrito<sup>62</sup>. Es curioso el hecho de que ning&#250;n instrumento espec&#237;fico para la insuficiencia card&#237;aca haya sido utilizado en los estudios evaluados. Porque sabemos que una significativa proporci&#243;n de pacientes evoluciona con insuficiencia card&#237;aca despu&#233;s de un evento coronario agudo, y que las informaciones de calidad de vida en los pacientes que evolucionan con una grave disfunci&#243;n ventricular en el per&#237;odo inicial despu&#233;s del evento coronario agudo son escasas y cuando est&#225;n disponibles, se restringen a los cuestionarios generales.</p>
      <p>
        <bold>Limitaciones</bold>
      </p>
      <p>Los estudios incluidos en el metan&#225;lisis presentaron una heterogeneidad moderada. La escasez de informaciones disponibles nos impidi&#243; incluir en el an&#225;lisis solamente cohortes prospectivas, que indicasen con claridad la evoluci&#243;n de la calidad de vida en el per&#237;odo inicial y tard&#237;o despu&#233;s de un evento coronario agudo, impidiendo tambi&#233;n que una meta-regresi&#243;n se hiciese para la identificaci&#243;n de las restantes causas de heterogeneidad. </p>
      <p>Las evaluaciones de calidad de vida no fueron ajustadas para ninguna de las variables cl&#237;nicas o sociodemogr&#225;ficas investigadas, que consabidamente influyeron en el resultado de las puntuaciones obtenidas. Los pacientes incluidos en los estudios no fueron homog&#233;neos en cuanto al tiempo, la gravedad de la enfermedad y en cuanto a las variaciones culturales entre Brasil y Portugal. Adem&#225;s, los estudios transversales incluidos en el an&#225;lisis, fueron categorizados en una evaluaci&#243;n precoz o tard&#237;a, siendo que la informaci&#243;n faltante fue imputada con base en el promedio ponderado de los dem&#225;s estudios dentro de la misma categor&#237;a. Por lo tanto, la comparaci&#243;n anterior y posterior, fue hecha con base en la comparaci&#243;n de los estudios y no de los grupos pareados en las figuras presentadas, excepto para las puntuaciones resumidas del cuestionario SF-36. Las variaciones en los promedios de las puntuaciones tambi&#233;n pueden estar relacionadas con las intervenciones propuestas para el tratamiento de los pacientes que no fueron evaluadas en este an&#225;lisis.</p>
      <p>Esos factores en su conjunto, impiden una interpretaci&#243;n m&#225;s exacta del comportamiento de la calidad de vida en los pacientes brasile&#241;os o portugueses que sufren un evento coronario agudo, y las diferencias entre la evaluaci&#243;n precoz y tard&#237;a debe ser vista con cautela. Tales informaciones, sin embargo, tambi&#233;n pueden ser &#250;tiles para formular hip&#243;tesis y para la elecci&#243;n del instrumento m&#225;s apropiado para evaluar a esas poblaciones. </p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>A pesar de las limitaciones, esta revisi&#243;n sintetiza los estudios hechos con instrumentos para la evaluaci&#243;n de la calidad de vida, que fueron traducidos para el portugu&#233;s, demostrando las fallas en los m&#233;todos de validaci&#243;n y dejando claro que las informaciones en cuanto a la evoluci&#243;n de la calidad de vida en los pacientes brasile&#241;os o portugueses que sufren un evento coronario agudo, todav&#237;a son necesarias. Se registr&#243; un aumento significativo en las puntuaciones de calidad de vida de 0,55 puntos para el cuestionario de MacNew y de 5,8 puntos para el cuestionario SF-36. Esta revisi&#243;n puede ser &#250;til para la elaboraci&#243;n, el proyecto y la ejecuci&#243;n de estudios futuros en esa &#225;rea.</p>
      <p>
        <bold>Agradecimientos</bold>
      </p>
      <p>Queremos agradecerle al Prof. Thomas M. Sakae por la r&#225;pida respuesta a los contactos hechos y por la colaboraci&#243;n en el suministro de los datos no publicados que fueron importantes para este an&#225;lisis. Tambi&#233;n a la Bibliotecaria Maria Eduarda Puga por su valiosa orientaci&#243;n en la construcci&#243;n de la estrategia de b&#250;squeda.</p>
      <p>
        <bold>Coinvestigadores</bold>
      </p>
      <p>Andrea Ferreira Haddad, Fabio Antonio Abrantes Tuche, Monica Amorim de Oliveira (Secretar&#237;a Municipal de Salud y Defensa Civil / SMSDC), Paola Martins Presta, Raphael Kasuo Osugue, Renato Correa Alves Moreira, Rodrigo Mousinho (Hospital Pr&#243;-Card&#237;aco), Karla Menezes, Rodrigo de Carvalho Moreira, Sabrina Bernardez (PROCEP Centro de Ensino e Pesquisa). </p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuve fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de tesis de Doctorado de Suzana Alves da Silva, por Escola Nacional de Sa&#250;de P&#250;blica S&#233;rgio Arouca / Fiocruz.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Quality of life assessment after acute coronary syndrome: systematic review</article-title>
      </title-group>
      <kwd-group xml:lang="en">
        <kwd>Acute coronary syndrome</kwd>
        <kwd>quality of life</kwd>
        <kwd>sickness impact profile</kwd>
        <kwd>review</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>REVIEW ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Quality of life assessment after acute coronary syndrome: systematic review</bold>
          </label>
          <p>
            <bold>Suzana Alves da Silva<sup>I,II,III</sup>; Sonia Regina Lambert Passos<sup>IV</sup>; Mariana Teixeira Carballo<sup>III</sup>; Mabel Figueir&#243;<sup>III</sup>; Investigadores<sup>II,V</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Escola Nacional de Sa&#250;de P&#250;blica - ENSP - Fiocruz, Rio de Janeiro - RJ, Brazil</p>
      <p><sup>II</sup>PROCEP Centro de Ensino e Pesquisa, Rio de Janeiro - RJ, Brazil</p>
      <p><sup>III</sup>Hospital do Cora&#231;&#227;o - IEP - Hcor, Rio de Janeiro - RJ, Brazil</p>
      <p><sup>IV</sup>Instituto de Pesquisa Cl&#237;nica Evandro Chagas - IPEC - Fiocruz, Rio de Janeiro - RJ, Brazil</p>
      <p><sup>V</sup>Secretaria Municipal de Sa&#250;de e Defesa Civil - SMSDC-RJ<sup>V</sup>, Rio de Janeiro - RJ, Brazil</p>
      <p>Mailing Address</p>
      <p><bold>Keywords:</bold> Acute coronary syndrome, quality of life, sickness impact profile, review.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>The Acute Myocardial Infarction (AMI) has been known worldwide since the beginning of the twentieth century as an almost always fatal disease. The physical and psycho-emotional impact caused by the disease and the high prevalence of depression have been described as the major factors that contribute to the impairment of quality of life (QOL) of patients in the medium and long-term<sup>1-3</sup>.</p>
      <p>A systematic review of studies evaluating QOL after acute myocardial infarction demonstrated that the effects of infarction on the QOL dissipate in the long term, but specific evaluation of patients who develop left ventricular function impairment in the acute phase of the event, does not seem to have been investigated<sup>4</sup>. In addition, two studies indicate that the consequences of both chronic ischemic heart disease and heart failure are not temporary, and their effects on QOL assessment worsen soon after diagnosis with no improvement in patient follow-up, differently from what has been observed after an acute event<sup>4,5</sup>.</p>
      <p>Although health systems always focus on morbidity and mortality control, recent concerns have also encouraged the evaluation of the impact of health hazards on patients' daily life. These assessments are usually carried out using questionnaires developed and validated through a specific methodology, which involves replication in other populations rather than the original population for which they were developed.</p>
      <p>There are several instruments to assess QOL in patients with ischemic heart disease and specific methodologies have been developed for the translation, cultural adaptation and interpretation of instruments when used in other languages. This systematic review aims at analyzing which instruments translated into Portuguese were used to assess quality of life in patients with acute coronary syndrome (ACS) and the interpretation of their results according to their psychometric properties.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>
        <bold>Search strategy</bold>
      </p>
      <p>The literature search was performed by a librarian specialized in the medical science field and saved using reference management software (Endnote, release 13.0). The search was not restricted to language or periods. The gateways, their respective databases and syntax used are described in <xref ref-type="table" rid="en_a13tab01m-body3">Table 1</xref>. We performed a manual search of relevant cross-references.</p>
      <p content-type="asset">
        <table-wrap id="en_a13tab01m-body3">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt01-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Criteria for reference selection and data extraction</bold>
      </p>
      <p>Reference selection and data collection were performed according to Prisma guideline<sup>6</sup>, by pairs of trained independent researchers.</p>
      <p>Reference selection was carried out by reading the abstracts of the available literature (<xref ref-type="table" rid="en_a13tab01m-body3">Table 1</xref>) and data extraction was performed by reading the full texts of selected references for the variables of interest.</p>
      <p>The analysis included all studies that evaluated the quality of life of patients with acute coronary syndrome or myocardial infarction, using instruments translated into Portuguese.</p>
      <p>The studies were included in the analysis regardless of the design and follow-up extent. Studies with results that were out of scale variation range were excluded.</p>
      <p>
        <bold>Selected variables and outcomes of interest</bold>
      </p>
      <p>We analyzed the quality of life (QOL) outcomes defined as the total and summarized scores of each instrument, according to the time elapsed between the diagnosis of acute coronary syndrome and the instrument application, as well as according to the clinical characteristics and socio-demographic profile of the population included in analysis. The validity results, including criterion (sensitivity, specificity, likelihood ratio) and construct validity (Pearson's, Spearman's or Kendall's correlation coeficient), reliability, including internal consistency (Cronbach's alpha test) and reproducibility (Intraclass coefficient of correlation or weighted kappa) and sensitivity, responsiveness, and interpretability were investigated and only the results found were described.</p>
      <p>
        <bold>Statistical Analysis</bold>
      </p>
      <p>The selected references and data collected were entered into an ACCESS database, release 2007, built specifically for this purpose.</p>
      <p>Quantitative variables were summarized by means and standard deviations as measurement of quality of life scores and psychometric properties of the evaluated instruments. Heterogeneity between studies was assessed based on Cochrane's Q<sup>2</sup> Test with a significance level of 10%<sup>7</sup>. The I<sup>2</sup> test was also used to quantify the heterogeneity among studies on a scale from 0 to 100%. Studies with I<sup>2</sup>&gt; 75% were considered highly heterogeneous. Weighted means and standard deviations of quality of life scores were pooled together according to the methodology standardized by Cochrane<sup>8</sup>.</p>
      <p>Data from the longitudinal studies were consolidated by a random-effect model that considered the Inverse of Variance as a weight measure to compare results before and after in relation to the time of questionnaire application. This moment was defined in relation to the ACS diagnosis and stratified as: <underline>&lt;</underline> 2 months and &gt; 2 months and compared between them. For the cross-sectional studies, the comparison between the two moments was made considering the data imputed from the weighted mean of the other studies in that period (before or after). Statistical tests were performed using the RevMan 5 (Cochrane) program, considering a significance level of 5%. All tests were two-tailed.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>
        <bold>Reference selection and characteristics of studies included in the review</bold>
      </p>
      <p>The search strategy results and reference selection are depicted in <xref ref-type="fig" rid="en_a13fig01m-body3">Figure 1</xref> and the characteristics of the selected studies are shown in <xref ref-type="table" rid="en_a13tab01m-body3">Table 1</xref>. We found four reviews<sup>9-12</sup> that were used as basis for cross-reference search.</p>
      <p content-type="asset">
        <fig id="en_a13fig01m-body3">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gf01-en.jpg"/></fig>
      </p>
      <p>Of 2,990 reviewed abstracts, eighteen full texts were included in the qualitative synthesis, of which: three cohort studies<sup>13-15</sup>, two case-control studies<sup>16,17</sup>, eleven sectional studies<sup>18-28</sup>, one non-randomized clinical trial<sup>29</sup> and one randomized clinical trial<sup>30</sup>. Three abstracts of which full texts were not published<sup>31-33</sup> and two duplicated publications<sup>34,35</sup> were excluded. Significant loss to follow up was observed in seven of the eighteen studies that were included. Three studies used different instruments that could not be included in the quantitative synthesis: one used the Seattle questionnaire<sup>15</sup>, one used the IPQ (Illness Perception Questionnaire)<sup>28</sup> and one the NHP (Nottingham Health Profile)<sup>16</sup>. Four studies contributed to the meta-analysis (<xref ref-type="fig" rid="en_a13fig01m-body3">Figure 1</xref>).</p>
      <p>Post-ACS quality of life was evaluated in selected populations from the south and southeast regions of Brazil, as well as the districts of Porto and Coimbra in Portugal; the vast majority of the patients were treated at cardiology outpatient clinics and rehabilitation programs of universitarian hospitals (<xref ref-type="table" rid="en_a13tab02m-body3">Table 2</xref>).</p>
      <p content-type="asset">
        <table-wrap id="en_a13tab02m-body3">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt02-en.jpg"/></table-wrap>
      </p>
      <p>Patient selection in these studies was carried out by searching the medical or hospital records and the sample size was defined by convenience. The time elapsed from ACS diagnosis to the questionnaire application varied among studies and was unclear in two of them. In seven studies the time from diagnosis was less than two months and in nine it ranged from two months to twelve years. The questionnaire application method, whether by interview, telephone contact or self-application was described in only six studies, was unclear in two studies and was not reported in the others (T<xref ref-type="table" rid="en_a13tab02m-body3">able 2</xref>).</p>
      <p>Most studies did not report on the previous history, habits, except for smoking, and socio-demographic characteristics of the studied populations (<xref ref-type="table" rid="en_a13tab03m-body3">Table 3</xref>). None of the selected studies adjusted their results for any of these characteristics. Family income was less than four minimum wages<sup>19,25,26,28</sup> and the level of schooling was less than four years in more than 50% of the studied population, except for the study by Dias et al<sup>13</sup>, which excluded patients with low educational level. Only two studies described the percentage of patients that returned to work after the coronary event, ranging from 26%<sup>19</sup> to 52%<sup>28</sup>.</p>
      <p content-type="asset">
        <table-wrap id="en_a13tab03m-body3">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt03-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Quality of Life Questionnaires</bold>
      </p>
      <p>The most widely used QOL questionnaires were: SF-36 in nine studies; MacNew in six studies; WHOQOL in three of them and Seattle, IPQ and NPH in one study each. The summarized and overall scores obtained in the periods before and after two months, and the mean of the difference between the two points are shown for the SF-36 and MacNew questionnaires in <xref ref-type="fig" rid="en_a13fig02m-body3">Figures 2</xref> and <xref ref-type="fig" rid="en_a13fig03m-body3">3</xref>, respectively, for both cross-sectional and longitudinal studies.</p>
      <p content-type="asset">
        <fig id="en_a13fig02m-body3">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gf02-en.jpg"/></fig>
      </p>
      <p content-type="asset">
        <fig id="en_a13fig03m-body3">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gf03-en.jpg"/></fig>
      </p>
      <p>The two meta-analysis performed for the longitudinal studies suggest QOL improvement in the late follow-up of 0.55 (95%CI: 0.34 to 0.76) for the MacNew questionnaire and 5.87 (95%CI: 3.42 to 8.31) for the SF-36 questionnaire compared with the initial follow-up of up to two months after the ACS diagnosis.</p>
      <p>The weighted means of the SF36, MacNew and WHOQOL<sup>36</sup> and the Seattle results observed in the study by Souza et al<sup>15</sup> were similar to those observed in patients with acute coronary syndrome in other countries (<xref ref-type="table" rid="en_a13tab04m-body3">Table 4</xref>)<sup>37-40</sup>, and lower than the scores observed in the general population of the United States and other countries (<xref ref-type="table" rid="en_a13tab04m-body3">Table 4</xref>)<sup>41</sup>, except for the summarized measurements, which had a behavior more similar to that of the general population in other countries than with the ACS population<sup>42</sup>.</p>
      <p content-type="asset">
        <table-wrap id="en_a13tab04m-body3">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt04-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Psychometric Properties</bold>
      </p>
      <p>The psychometric properties of the MacNew, SF36 and WHOQOL questionnaires were evaluated in four of the eighteen analyzed studies. Convergent validity (a type of construct validity) was analyzed using Pearson's correlation between the MacNew, disease-specific, and SF-36, general, questionnaires (Alc&#226;ntara<sup>25</sup>, Leal et al<sup>14</sup> and Nakajima et al<sup>19</sup>), and between the WHOQOL-brief and SF-36 questionnaires, both general (Cruz et al<sup>26</sup>).</p>
      <p>Correlations between MacNew and SF-36 scores were &gt; 0.6 for mental health, vitality and functional capacity scores <sup>19</sup>.The emotional score of MacNew questionnaire showed correlation values &gt; 0,6 with only two domains of SF-36: mental health (r = 0,78) and vitality (r = 0,69) <sup>19,25</sup>.The correlations between the physical component of the SF-36 and MacNew overall and physical scores were 0.70 and 0.72, respectively, and between the mental component of SF-36 and the emotional score of MacNew was 0.78 (Leal et al<sup>14</sup>).</p>
      <p>The correlation between the emotional score of the two questionnaires ranged from -0.15 (Alcantara et al<sup>25</sup>) to 0.45 (Nakajima et al<sup>19</sup>) and between the social scores, it ranged from 0.49 to 0.58 between the studies<sup>14,19,25</sup>. Leal et al<sup>14</sup> observed significant correlations (r &gt; 0.70) between the overall and summarized scores of both questionnaires in the same dimensions (physical component of SF-36 vs. overall score and physical score of MacNew and mental component of SF -36 vs. MacNew emotional score). Cruz et al<sup>26</sup> found significant Pearson's correlation (r &gt; 0.55) between the physical score of the WHOQOL and all scores of SF-36 (except for the physical impairment and emotional state scores) and between the WHOQOL psychological score and the mental health and vitality scores of SF-36. The vitality (r = 0.58) and mental health scores of SF-36 (r = 0.68) and all WHOQOL scores (r&gt; 0.55) moderately correlated with Beck's depression questionnaire<sup>26</sup>.</p>
      <p>Discriminant validity (another type of construct validity) was investigated in the studies by Nakajima et al<sup>19</sup> and Leal et al<sup>14</sup>. Patients with severe ventricular dysfunction had significantly lower QOL scores compared to those with mild or moderate ventricular dysfunction<sup>19</sup>. The MacNew questionnaire was able to significantly discriminate patients with severe LV dysfunction from the others, as well as patients with progressive worsening in SF-36 scores from those with improvement or no change in these scores. The MacNew questionnaire was also able to differentiate patients with and without depression or anxiety using the hospital scale for anxiety and depress&#227;o<sup>14</sup>.</p>
      <p><underline>Internal consistency</underline> (Cronbach-&#945;) of SF-36 and WHOQOL, evaluated by Cruz et al<sup>26</sup> was &gt; 0.7 for all dimensions except for the social score. In the studies by Nakajima et al<sup>19</sup> and Leal et al<sup>14</sup>, which evaluated the MacNew questionnaire, internal consistency was &gt; 0.8 for all dimensions. These results are similar to what was observed in other countries (<xref ref-type="table" rid="en_a13tab05m-body3">Table 5</xref>)<sup>43-46</sup>.</p>
      <p content-type="asset">
        <table-wrap id="en_a13tab05m-body3">
          <graphic xlink:href="1678-4170-abc-97-06-0526-00013-gt05-en.jpg"/></table-wrap>
      </p>
      <p><underline>Reproducibility</underline> was assessed exclusively by Leal et al<sup>14</sup> using the test-retest intraclass correlation for the MacNew questionnaire, with results ranging from 0.77 to 0.93, also showing results that were similar to those observed in other countries (<xref ref-type="table" rid="en_a13tab05m-body3">Table 5</xref>)<sup>44</sup>.</p>
      <p>The <underline>floor-ceiling effect</underline>, present when &gt; 10%<sup>47</sup>, was observed in the "emotional state" and "physical impairment" scores of SF-36 evaluated in the study by Cruz et al<sup>26</sup>. This effect was not present in the MacNew questionnaire evaluated in the study by Leal et al<sup>14</sup>.</p>
      <p>
        <bold>Heterogeneity</bold>
      </p>
      <p>The longitudinal studies included in the meta-analysis showed moderate heterogeneity. Meta-regression analysis to evaluate the causes of heterogeneity was not performed due to the absence or inconsistency of information in most studies. Possible causes of heterogeneity may be related to different study designs included in the analysis and methods used for the selection of research subjects and questionnaire application. Another possible source of heterogeneity was the time elapsed between the ACS and questionnaire application, mainly in the group classified as evaluation "&gt; two months," which ranged from three months to six years from the diagnosis. In addition, for the cross-sectional studies, other studies included in the analysis within the same category imputed based on the weighted mean of other studies included in the analysis within the same category, so that the comparison of means before and after could be performed for the studies that were found. The clinical and socio-demographic characteristics, when reported, also varied widely between studies and seem to be homogeneous only for age range and sex (<xref ref-type="table" rid="en_a13tab03m-body3">Table 3</xref>).</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>This systematic review is a survey of what was produced in Brazil and Portugal in relation to the subject "quality of life" in acute coronary disease, taking into account the results of quality of life scores measured by different instruments, according to time of disease and their psychometric properties.</p>
      <p>The psychometric properties of the instruments were assessed in only four of eighteen studies analyzed, three of which evaluated the association of a general questionnaire (SF-36) to a specific questionnaire (MacNew) and are discussed below.</p>
      <p>
        <bold>Construct validity</bold>
      </p>
      <p>Construct validity was assessed according to previously established methods<sup>48,49</sup> and showed: 1) high convergence between the items of the MacNew and SF-36 questionnaires, considering the same construct, except for the emotional scores, probably because they measure different quality of life aspects. While the MacNew questionnaire deals with the patient's perception, SF-36 is concerned with the impact of the emotional state on their daily activities, 2) high convergence was observed among all dimensions of the WHOQOL-brief and only the mental health score of SF -36, but not between the other scores of this instrument, probably as a consequence of the fact that the two questionnaires have very different scopes. While the SF-36 was designed to assess health status, the WHOQOL was designed to assess the patient's perception regarding the different aspects of his/her life, in an overall manner, 3) low discriminating capacity of the general questionnaires in opposition to the good discriminating capacity of the MacNew specific questionnaire for changes in quality of life related to heart failure or depression symptoms, and 4) moderate discriminating capacity of the WHOQOL questionnaire for the presence of depression.</p>
      <p>The analyses of construct validity of the discriminant type were restricted to the MacNew questionnaire, which showed good discriminating capacity between patients with and without severe ventricular dysfunction, depression and anxiety compared to longitudinal observations with the SF-36. Functional classes of angina or heart failure were not evaluated, but previous studies have suggested that these questionnaires have low discriminant power for these items<sup>3</sup>.</p>
      <p>Criterion validity was not assessed in any of the studies included in this review and its importance would relate primarily to determine performance, mainly of specific instruments to define the presence or absence of clinical conditions of interest, such as re-obstruction of coronary vessels or heart failure during the clinical follow-up of these patients.</p>
      <p>
        <bold>Reliability</bold>
      </p>
      <p>The internal consistency assessed by Cronbach's &#945; was low for the social score of the general questionnaires, both SF-36 and WHOQOL, whereas the specific questionnaires Seattle and MacNew behaved differently from the general questionnaires and had high internal consistency in all their dimensions.</p>
      <p>Reproducibility, considered satisfactory when &gt; 0.50 for comparison between groups and &gt; 0.90 when comparing the individual with him or herself<sup>44,47</sup>, was evaluated only for the MacNew questionnaire in 1 study, demonstrating that this questionnaire showed high reliability in the studied population<sup>14</sup>.</p>
      <p>
        <bold>Sensitivity</bold>
      </p>
      <p>The SF-36 dimensions that address the emotional state and social function showed a high floor-ceiling effect, which was also moderately present in the dimensions of body pain and physical impairment, consistent with what was seen in previous studies<sup>45,46</sup>. The propensity to the floor-ceiling effect was low for both specific questionnaires, MacNew and Seattle. Although the floor-ceiling effect has been described as a good parameter to infer the sensitivity of QOL instruments, as it demonstrates whether the instrument is able to detect variations between individuals rather than the extremes of the measurement, it is a method considered by many authors as insufficient to assess whether the instrument is capable of detecting small differences<sup>50</sup>. The method that has been proposed for the assessment of this property is that of the magnitude of the effect between groups through specific statistical tests, such as Cohen's size effect, Guyatt responsiveness index and the standardized mean difference, which was not was performed in any of the analyzed studies<sup>50,51</sup>.</p>
      <p>
        <bold>Responsiveness</bold>
      </p>
      <p>The interpretation of changes in QOL scores over time is another question of great importance when following patients with ischemic heart disease<sup>52</sup>. The floor-ceiling effect has also been used as a useful indicator of instrument responsiveness<sup>50</sup>, but the most widely used concept in the literature is the "minimal important difference" (MID), which represents the smallest difference in score of the domain of interest that is perceived by the patient and would determine, in the absence of clinical or financial limitations, the change in therapeutic conduct<sup>53,54</sup>. Norman et al<sup>54</sup>, based on a systematic review of QOL studies, showed that the MID can be estimated based on half of the standard deviation of the mean scores resulting from the initial instrument application in that population<sup>54</sup>. It has been shown that a change of at least 0.5 and 3.5 are useful indicators for MID in the scores of the MacNew and Seattle questionnaires, respectively<sup>55,56</sup>.</p>
      <p>For the SF-36 questionnaire, a variation of around 10 points for the individual scores represented a marked change in the perception of the patients' health, whereas a change of about 5 points represented a moderate change<sup>57</sup>. In this review, only four of eighteen studies allowed this analysis, with values of 0.55 found for MacNew and 5.78 points for the SF-36, consistent with what has been established as the MID for these instruments. A change of approximately fifteen points was observed in the only study that evaluated the Seattle questionnaire<sup>15</sup>. This large variation may be related to the time of the first application of the instrument carried out at hospital admission, when the patient presented acute symptoms<sup>15</sup>. With the exception of the Seattle questionnaire, these findings corroborate the results of the systematic review by Simpson, which suggests a modest QOL recovery after an acute coronary event<sup>58</sup>.</p>
      <p>The results of a previous systematic review, performed by Dempster et al<sup>59</sup> suggest that the general questionnaires such as SF-36 and Nottingham Health Profile have low responsiveness and therefore their results should be interpreted with caution, as these instruments are little sensitive to the observation of small evolution variations in QOL of patients with ischemic heart disease. In addition to Dempster, other authors have suggested that a specific questionnaire should always be associated with a general questionnaire to assess the quality of life in patients with ischemic heart disease<sup>3,59</sup>.</p>
      <p>
        <bold>Transcultural validation</bold>
      </p>
      <p>Although the general instruments such as WHOQOL and SF-36, which were the most widely used in the assessed studies, in the vast majority as isolated instruments, have been validated in Portuguese in patients with clinical features that are completely different from those presented by patients with coronary disease<sup>60,61</sup>, preliminary assessments suggest that at least SF-36 has high reliability in different cultures and in different clinical conditions, and in Brazil, it showed adequate reproducibility in a population of patients with stable angina<sup>62</sup>. The other instruments (Seattle, MacNew and NHP), which are disease-specific, have been validated in the population of interest. Although there are records of translation and validation of the Seattle questionnaire for Brazilian patients with stable angina, details of the transcultural translation process have not been described<sup>62</sup>.</p>
      <p>It is noteworthy the fact that no specific instrument for heart failure has been used in the evaluated studies. It is known that a significant proportion of patients develops heart failure after an acute coronary event and that quality of life information in patients who develop severe ventricular dysfunction in the initial period after the acute coronary event are scarce and when available, restricted to the general questionnaires.</p>
      <p>
        <bold>Limitations</bold>
      </p>
      <p>The studies included in the meta-analysis showed moderate heterogeneity. The scarcity of available information prevented the inclusion of only prospective cohort studies, which would clearly demonstrate the evolution of quality of life in the early and late periods after an acute coronary event, also preventing a meta-regression to identify other causes of heterogeneity.</p>
      <p>The quality of life assessments were not adjusted for any of the clinical or socio-demographic variables studied, which are known to influence the outcome of scores. Patients enrolled in the studies were not homogeneous regarding disease time and severity, as well as the cultural variations between Brazil and Portugal. Moreover, the cross-sectional studies included in the analysis were categorized into early or late evaluation, and the missing information was imputed based on the weighted mean of the other studies within the same category. Therefore, the before and after comparison was based on study comparison and not on paired groups shown in the figures, except for the summarized scores of SF-36. Variations in mean scores may also be related to the proposed interventions for the treatment of patients, which have not been evaluated in this analysis.</p>
      <p>These factors together prevent an accurate interpretation of the quality of life behavior in Brazilian and Portuguese patients suffering from acute coronary events and the differences between early and late assessment must be viewed with caution.</p>
      <p>Such information, however, may be useful in formulating hypotheses and selecting the most appropriate instrument for the assessment of these populations.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>In spite of the limitations, this review summarizes the studies carried out with instruments to evaluate quality of life, which have been translated into Portuguese, demonstrating flaws in the methods of validation and showing that information on the evolution of the QOL in Brazilian or Portuguese patients that have suffered an acute coronary event are still necessary. There has been a significant increase in the quality of life scores of 0.55 points for the MacNew questionnaire and of 5.8 points for SF-36 questionnaire. This review can be useful to create, design and carry out further studies in this area.</p>
      <p>
        <bold>Acknowledgements</bold>
      </p>
      <p>We thank Prof. Thomas M. Sakae for the prompt response to our contact and collaboration in providing non-published data that were important for this analysis and to librarian Maria Eduarda Puga for her invaluable help in creating the search strategy.</p>
      <p>
        <bold>Co-Investigators</bold>
      </p>
      <p>Andrea Ferreira Haddad, Fabio Antonio Abrantes Tuche, Monica Amorim de Oliveira (Health and Civil Defense Secretary/SMSDC-RJ), Paola Martins Presta, Raphael Kasuo Osugue, Renato Correa Alves Moreira, Rodrigo Mousinho (Pr&#243;-Card&#237;aco Hospital), Rodrigo de Carvalho Moreira, Karla Menezes, Sabrina Bernardez (PROCEP Teaching and Research Center).</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of doctoral submitted by Suzana Alves da Silva, from Escola Nacional de Sa&#250;de P&#250;blica S&#233;rgio Arouca / Fiocruz.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
